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Protein conformationSecondary active transporters couple the free energy of the electrochemical potential of one solute to the
transmembrane movement of another. As a basic mechanistic explanation for their transport function the
model of alternating access was put forward more than 40 years ago, and has been supported by numerous
kinetic, biochemical and biophysical studies. According to this model, the transporter exposes its substrate
binding site(s) to one side of the membrane or the other during transport catalysis, requiring a substantial
conformational change of the carrier protein. In the light of recent structural data for a number of secondary
transport proteins, we analyze the model of alternating access in more detail, and correlate it with speciﬁc
structural and chemical properties of the transporters, such as their assignment to different functional states
in the catalytic cycle of the respective transporter, the deﬁnition of substrate binding sites, the type of
movement of the central part of the carrier harboring the substrate binding site, as well as the impact of
symmetry on fold-speciﬁc conformational changes. Besides mediating the transmembrane movement
of solutes, themechanism of secondary carriers inherently involves amechanistic coupling of substrate ﬂux to
the electrochemical potential of co-substrate ions or solutes. Mainly because of limitations in resolution
of available transporter structures, this important aspect of secondary transport cannot yet be substantiated
by structural data to the same extent as the conformational change aspect. We summarize the concepts of
coupling in secondary transport and discuss them in the context of the available evidence for ion binding to
speciﬁc sites and the impact of the ions on the conformational state of the carrier protein, which together lead
to mechanistic models for coupling.iversity of Köln, Zülpicher Str.
+49 221 470 5091.
.
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Secondary transporters are ubiquitously distributed molecular
machines found in every cell. They couple the energy of the
transmembrane electrochemical potential of one solute to that of
another, leading to an uphill ﬂux of the latter and thus to its
accumulation in the trans compartment. This process is secondary
only in the sense that the source of energy, the electrochemical
gradient, must ﬁrst be generated by ATP-dependent mechanisms,
which in turn is known as primary transport. Since the ﬁrst
formulation of the principle events in transport [1], their transforma-
tion into concepts of secondary transport mechanisms [2], and the
description of the basic principles of the alternating access model for
transport [3], the application of numerous biochemical, biophysical
and theoretical approaches has enabled the elaboration of the
concepts of secondary carrier function. Nevertheless, the basic notion
of a transporter being a membrane-bound enzyme that, in contrast to‘normal’ enzymes, changes the location, and not the chemical nature
of its substrate, is still valid.
In order to gain a deeper understanding of carrier catalysis,
however, this basic concept needs to be complemented by detailed
knowledge of the biochemical properties and the tertiary structure of
transporters. In recent years, the availability of 2D and 3D structures
obtained by X-ray and EM crystallography, as well as contributions
from computational and theoretical approaches, has greatly enhanced
our understanding of the molecular function of these membrane
proteins. Despite these advancements, the number of well-resolved
3D structures of membrane-bound transporters is still rather limited
in comparison to the numerous high-resolution structures available
for soluble enzymes. Moreover, transport is inherently a dynamic
process and cannot be completely understood solely on the basis of
static pictures, even if they are of high resolution. Consequently, in
spite of the growing amount of structural information, we are to a
large extent still lacking supplementary information about the
dynamic aspects of carrier function.
An important conceptual foundation for the understanding of
secondary transport, still valid even considering the most recent
developments, is the alternate accessmodel of transport. Thismodel is
based on early descriptions of membrane transport function [1,4,5],
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the catalytic cycle of a transporter does not involve a signiﬁcant
movement of the substrate binding site relative to the membrane, but
rather, upon sequential conformational changes of the carrier protein,
a sequential exposure, i.e., alternate accessibility of this site to one side
of the membrane or the other. This concept has since been developed
and reﬁned based on kinetic and biochemical studies as well as on
theoretical considerations, by the description of substrate permeation
pathways, gating functions, and speciﬁc conformational constraints,
leading to detailed descriptions of putative conformational events
and related kinetic steps in speciﬁc carrier proteins [6–11].
Another essential foundation is the formulation of the energetics
of transport. The function of transporters, like that of enzymes, can
be described by basic energetic principles, which, in turn, have
fundamental mechanistic implications. However, while an elaborate
theoretical framework has been developed for enzyme catalysis (e. g.
[12]), the application of these principles to transport has received
only limited attention [7,9,13–15]. This probably reﬂects the fact that,
in contrast to enzymes, carriers do not change the chemical nature of
their substrates and, consequently, a transition state does not appear
to make much sense in the context of transport catalysis. Theoretical
descriptions and experimental analysis of carrier catalysis, however,
have shown that transport proteins in fact work in rather similar ways
to enzymes. Just like enzymes, these sophisticated energy converters
utilize the energy of substrate binding to reduce the high free
energy barrier of the empty carrier protein down to the level of the
transition-state complex between the transporter and its substrate,
in a way that guarantees suitably high rates of transport [15,16].
Beyond the alternating access model and the fundamental
principles of transport energetics, the development of more detailed
functional models for a particular transporter requires the availability
of a wealth of biochemical data, either from transport kinetics with
wild-type and mutant forms of the protein (such as Kd and Kt (Km of
transport) of substrate,Vmax, substrate speciﬁcity, deﬁnition of binding
order, electrophysiological parameters), or from the application of
biochemical and biophysical techniques such as cross-linking, spec-
troscopy (e.g., ﬂuorescence, FRET, EPR, NMR), covalent modiﬁcation,
accessibility measurements, and many more.
Currently the most stimulating contribution to our understanding
of secondary transport is the fast growing amount of structural data
on transport proteins. This impact is particularly signiﬁcant when
crystal structures are available for a given transporter in different
states, e.g., with and without bound substrate/co-substrate, reﬂecting
various conformational states in the catalytic cycle of transport, or
corresponding to different levels of activation.
Building on these structural data, impressive progress in compu-
tational techniques is providing an additional source of valuable
information, in particular for developing ideas on dynamic and
energetic aspects of transporter function. The exploitation of
structural data and their use for computational studies will be the
major focus of this review.
Indeed, for a number of opportune cases, the combination of
results from a multitude of different approaches and sources of
information has recently allowed the proposal of elaborate concepts
for the function of carrier proteins, or structural elements thereof
[17–22]. In this review we will attempt to describe what has been
learned by these studies. In spite of the developments of the past few
years, we are still far from a true understanding of the microscopic
mechanisms of these fascinating molecular machines. Speciﬁcally, in
our view, three key lines of evidence are still lacking or remain
insufﬁciently described.
First, we do not know enough about the dynamics of carrier
proteins as they proceed through the catalytic cycle of transport. This
refers both to the question of how many discernable conformational
intermediates within the transport cycle we need to consider and
what their properties are, and also to the dwell time of these differentintermediates within the cycle. We would like to know, for example,
which conformational states are transient and which are relatively
stable. This latter question is closely connected to an understanding of
how particular conformational events in the transport cycle of a
carrier correlate with speciﬁc energetic states in carrier catalysis,
which to date has been derived mainly from theoretical considera-
tions [16].
The second area relates to the diversity of carrier structures. A
surprising result of the growing number of available 3D structures of
transporters is that many of these proteins – even though they lack
signiﬁcant sequence similarity, and consequently have been assigned
to different carrier families – are nevertheless characterized by a
similar structural fold. Even more surprising is the observation that
what is most probably the coremachinery of transport catalysis seems
to use a common construction, i.e., an inverted structural symmetry
motif within the carrier protein. However, because of the small
number of examples, the lack of sufﬁcient resolution of particular
structures, or limited information on their dynamic behavior, it is
currently not fully clear whether basic mechanistic principles derived
for speciﬁc transporters, mainly those with the LeuT fold (see below),
are in fact valid for all other transporters aswell. Although this appears
to be merely a theoretical consideration, an answer to this question
will have important consequences, for example with respect to
understanding the way in which diverse systems have evolved from
primordial structural elements in this functional class of proteins.
A third area where information is still scarce relates to coupling,
and speciﬁcally, the principles that guide the requirement for a
speciﬁc ion to be co- or counter-transported with the substrate in
coupled transport. Aside from considering the conformational events
in the catalytic cycle (discussed above), previous kinetic, energetic
and biochemical models have also focused on deﬁning the principles
of coupling between driving forces and substrate movement.
Nevertheless, the question of coupling is, in our opinion, still poorly
understood. In particular, the different models currently put forward
for speciﬁc transporters or carrier families differ signiﬁcantly in their
accounting for the principles of coupling. This has signiﬁcant
consequences for the understanding of important aspects of second-
ary transport, e.g., for the functional meaning of 'gate elements' during
the transport cycle, or for the question of how similar the formally
distinct mechanisms of symport and antiport are in molecular terms.
In other words: should it be possible to discriminate an antiporter
from a symporter on the basis of recognizable structural elements?
In this review we will restrict ourselves to secondary transport.
Although there is a signiﬁcant overlap in basic principles between
primary and secondary transport, both with respect to energetic
principles and coupling concepts [6,11,13], the differences between
these types of transport mechanisms in conceptual, functional, and in
particular in structural aspects are signiﬁcant. For another interesting
class of transporters, namely, phosphotransferase systems, not
enough structural information is available for a similarly detailed
discussion. In addition, for obvious reasons, we will concentrate
mainly on those secondary transport systems for which structures at
reasonable resolution are available. Wewill, however, try to discuss as
many secondary carriers with known structures as possible, in order
to make this a broader review thanmost previous articles, which have
focused on only a couple of examples each. A more generalized view
will also help to close the gap between interesting carrier structures
and the wealth of biochemical knowledge that is available, at least
for some transport systems.
2. A uniform concept for secondary transport mechanism
A common foundation for discussing the mechanism of solute
transport has, for more than 40 years, been the model of alternating
access [3] (for review see [17,23]). According to this model, the
transporter exposes its substrate binding site(s) to one side of the
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between the twoalternate states involves a substantial conformational
change of the carrier protein. However, the extent to which the
substrate changes its location within the protein during transport
catalysis is not necessarily speciﬁed by this model, and in principle
may differ for different transporters. The kinetic description of the
alternating access model has been ﬂeshed out by subsequent
biochemical studies [8,10]. It was ﬁrst demonstrated convincingly on
an experimental basis for the mitochondrial ADP/ATP carrier, using
side-speciﬁc and thus conformation-speciﬁc inhibitor compounds
[7,24], andwas subsequently renamed the single-binding center gated
pore (SBCGP)model. Thismore speciﬁc nomenclature emphasizes the
fact that the mechanistic concept requires the presence of a central
binding site or, more precisely (for functional reasons), a binding
center, which is alternately exposed to the two sides of themembrane.
The SBCGP model also indicates that the presence of gates is an
important feature of carrier catalysis (see below).
We are now in a position to reﬁne the deﬁnition of the sequence of
conformational and functional states during carrier catalysis that was
originally laid out in the alternating access or the SBCGPmodels, in the
light of the recent structural data for transporters. Consequently, to
provide a foundation for a later discussion of speciﬁc structures and
mechanisms, we describe a typical series of conformational states
(Fig. 1) in which we differentiate between substrate (or substrates)
bound to an open (CSe and CSi) and an occluded form of the carrier
(CSce, CSc, and CSci). These different states will be discussed in the
context of the energy proﬁle of carrier catalysis described below. It
should be pointed out that the conﬁguration of the binding site, and
the steric context of the substrate sitting in the carrier protein, may
differ in the two alternative conformations, CSec and CSic, since both
the substrate and the binding site are typically not symmetric entities,
so the proﬁle of the binding site presented to the substrate may be
different in the two conformations. In the case that a single substrate
is transported during the conversion from CSec to CSic, (i.e., in the
absence of a co-substrate) then one of two things can happen: if the
return step occurs in the empty form (Ci→Ce) the result is a uniport
mechanism; if the return step involves the second, antiport substrate,
then the result is an antiport mechanism. In a symport mechanism,
the transport cycle is deﬁned by the inclusion of binding and release
steps of the co-substrate, which would be similar to those of the
substrate. Three of the states indicated in Fig. 1 are potentially not
well populated or, at least, may be difﬁcult to observe experimentally;
however, we have included them for conceptual reasons. Speciﬁcally,A








Fig. 1. A series of different conformational states during coupled transport. (A) Substrates (
transient substrate-bound state CSe, which transforms to an occluded substrate-bound state
facing, occluded substrate-bound state CSic passes through a fully occluded, probably tra
transient substrate-bound inward-facing open conformation (CSi) and the carrier can sw
intermediate state Cc in the case of symport (see text for details). (B) Theoretical energy pr
substrate-bound states, and a putative rate-limiting barrier for the re-conversion of the empt
situations are represented by additional proﬁles in gray.the two states CSe and CSi are expected to be transient. In addition,
the fully occluded state, CSc, may be a transient intermediate between
the two states CSec and CSic, at least for some transporters. Whether
experimentally observable or not, these three states, although
probably short-lived, are formally necessary intermediates and
helpful for describing the energy proﬁle of transport.
As mentioned above, gates may also play an important role in
carrier catalysis. It should be noted that the function “gating” was
originally introduced in the ion channel ﬁeld, where it signiﬁes
opening or closing of the pore of a channel in response to a particular
stimulus (electrical, chemical or mechanical) [25]. Thus, a gate in a
channel is a part of the channel pore that obstructs the passage of ions
when the channel is closed (or inactivated), and which changes its
conformation upon a stimulus to open a passage for the ions through
the channel. This designation has since been adopted for carriers,
but because of the differences in the function of transporters and
channels, it has a rather different meaning in at least two aspects.
First, a gate in carrier function is simply a particular (sub)domain of
the transporter protein that may regulate the accessibility of the
substrate binding site to/from the surroundings. Thus, its function is
essentially independent of substrate translocation. However, gating
is sometimes also given a second meaning in which it is applied to
the core function of carrier proteins, i.e., the massive conformational
change of the whole protein as a response to binding or release of the
substrate(s). Although this second usage of the expression 'gating'
seems similar to its usage for channels, it has a mechanistically
different meaning, as will be discussed below in the context of
energetic considerations (transfer of binding energy).
The intuitive perception that gating may have both these functions
in carrier catalysis, together with the observation that the putative
structural correlates of the two functions may be different sizes (see
section 3), have led to the somewhat imprecise designation of 'thin'
and 'thick' gates. A thin gate in this sense means a part of the protein
that can regulate the accessibility of substrates (according to the ﬁrst
meaning of gating described above) from one side of the carrier, e.g.,
from the 'e' side, if the transporter is in the Ce conformation. Opening
or closing of thin gates is not correlatedwith signiﬁcant changes of the
whole protein. In contrast, a thick gate has sometimes been assigned
to a core component of the carrier structure that will undergo
substantial conformational change when the transporter switches
between the Ce and Ci states (according to the second meaning of
gating described above) [18,21]. Thus, in Ce or Ci states of the carrier,
the structural unit assigned to the thick gate obstructs the substrateexternal
internal
CSic CSi Ci Cc
ΔG†
S, star and red circle) bind to an externally open carrier conformation (Ce), forming a
still facing the external side of themembrane (CSec). Switching from CSec to an inward-
nsient, substrate-bound intermediate state, CSc. Substrates are then released from a
itch back from inward open (Ci) to outward open (Ce) state via a fully occluded,
oﬁle (black) of different carrier states during catalysis, indicating minima at the gated
y carrier. Note that the barriers andminimawill vary for different transporters: alternate
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see section 3). That is, the thick gate occludes the substrate from the ‘i’
side if the transporter is in the Ce conformation, and vice versa. When
compared with the scheme in Fig. 1, the action of a thin gate is
represented by the catalytic steps CSe↔CSec and CSi↔CSic, whereas
opening and closing of a thick gate represents the CSec↔CSic
conversion that passes through the transient CSc state. In general,
although thin gates have a uniquely deﬁned function and thus add to
the cadre of useful descriptors for transporter function, we prefer to
avoid the use of thick gates in our terminology since its deﬁnition is
redundantwith that of themajor conformational switch, and since the
structural correlates of the thick gates are not trivial to deﬁne.
Support for these theoretical concepts, and particularly the
conformational switch between the two alternative states, was ﬁrst
shown biochemically for the mitochondrial ADP/ATP carrier, where
the entire population of carrier molecules could be switched from
an extracellular-facing conformation with the bound inhibitor
atractyloside to an intracellular-facing conformation induced by
binding of the inhibitor bongkrekate [7]. Importantly, this alternating
access of the binding site was only observed in the presence of the
substrates ADP or ATP, the binding of which triggered the conforma-
tional switch of the carrier protein, thus demonstrating the critical
contribution of substrate binding to these conformational events.
By considering the contribution of the substrate-carrier interac-
tion, or, more precisely, of binding energy to carrier catalysis, we
begin to view transport in basic energetic terms, and thus arrive at a
core understanding of carrier catalysis. As mentioned above, such
fundamental energetic concepts originate from treating coupled
vectorial processes (transport) as analogous to enzymatic processes.
Thus, the energy of substrate binding is used for smoothing the energy
proﬁle of the different states during carrier catalysis and to avoid low-
or high-energy intermediates along the reaction path, so as to
guarantee sufﬁciently high transport rates [16]. Concomitantly, the
concept of transition statewas introduced [7,14]. Because the chemical
nature of the substrate is not altered during transport, the occurrence
of a transition state, as in enzyme mechanisms, is not obvious.
However, also in the case of transport processes, a transition state
intermediate of the carrier protein structure is required to provide the
catalytic energy for the transport reaction (see below). In the current
view, the transition state is represented by an occluded state of the
carrier-substrate complex (CSc) and includes the associated function
of gates, both external and internal. At this point, a gate is simply
deﬁned operationally as a barrier between the substrate and the
internal or external surroundings, thus preventing kinetic equilibra-
tion of bound and free substrate. Its structural meaning will become
clear when discussing speciﬁc carriers.
It is important to note that, by analogy with enzyme kinetics, the
binding site in the two empty conformations of the carrier, Ce and Ci,
cannot form optimal interactions with the substrate (it does not ‘ﬁt’
perfectly) and, consequently, the binding energy cannot be exploited
fully in those states. Subsequently, however, binding of the substrate
enables a conformational change of the carrier, the intrinsic binding
energy is ‘stored’ in the carrier protein in the form of conformational
energy, and thus the energy of the transition state is lowered [16]. In
the transition state (occluded state, e.g., CSc) the binding site now
achieves an optimal ﬁt to the substrate, as in enzyme mechanisms.
In contrast to enzyme catalysis, however, the conﬁguration of the
substrate remains unchanged, or, in other words, the conformational
work is exclusively conﬁned to the carrier protein. By this mechanism,
the binding energy is utilized to facilitate speciﬁc conformational
changes of the transporter during its cycle from the external, via the
occluded, to the internal conformation, or vice versa. The energy
difference related to the sequence of conformational events in which
the transport protein changes, upon substrate binding, between states
of limited interaction with the substrate and the transition state
characterized by an intimate substrate-protein interaction, representsthe catalytic energy for transport. It is paid for by the intrinsic binding
energy of substrate-carrier interaction. This concept has been
introduced and described in terms of the so-called 'induced transition
ﬁt' mechanism [14].
Some important consequences of the induced transition ﬁt
concept should be mentioned here. The substrate has only a poor
afﬁnity to the carrier in the ground state(s), Ce and Ci, but it should
bind strongly to the carrier in the transition state. Consequently, good
substrates are discriminated from poor ones in general not by their
difference in binding to the ground states (empty carrier) but by their
interaction in the transition state (occluded state). Thus, transporter
speciﬁcity for different substrates is reﬂected in differences in rates
(Vmax) and not in half-saturation constants (Km) [26]. Interestingly,
this also means that good competitive inhibitors of transport may
differ structurally from the corresponding substrate, since they can
inhibit by providing optimal interactions with the ground state of the
carrier that lead to an energetic trap (i.e., a low-energy state).
It was our intention in this section to lay out a conceptual
framework within which we can make sense of the wealth of
structural data that will be discussed below. We will ﬁrst describe
current views of the structural basis of transport function, with a focus
on the conformational changes involved in the catalytic cycle of
carriers. Second, wewill attempt to use knowledge of carrier structure
and conformational dynamics to better understand the role of
functional coupling between electrochemical potentials and concen-
tration gradients of substrates and co-substrates. It is the goal of this
review to address questions on possible structural correlates of the
principles of solute transport as well as coupling and thus to bridge
the gap between concepts and their molecular understanding.
3. Towards a molecular understanding of secondary transport
through structure
Lack of atomic structural data has, for many years, created a
frustrating divide between the concepts of secondary transport and a
molecular understanding of its mechanisms. The recent increase in
the number of available transporter structures (Table 1), however, has
raised hope in our ability to bridge this gap. Reassuringly, most of the
structures reported to date appear to be perfectly consistent with the
alternating access model, and conﬁrm the existence of the confor-
mational states originally suggested on the basis of the alternating
access or SBCGP models [17–20,27–34]. They are apparently also
consistent with the proposal that substrate binding facilitates the
conformational changes in the carrier. In fact, evidence for both types
of conformational event, i.e., the opening or closing of thin gates, and
the concerted conformational switch between Ce and Ci states, is
found in carrier structures corresponding to the endpoints of those
conformational changes [19,27].
This agreement with the alternating access model seems to be
valid for transporters from a wide range of structural families.
Sequence data has revealed that secondary transporters are encoded
for by a very large number of unrelated gene families, which
themselves exhibit broad sequence variability [35]. Therefore, it was
not unexpected when transporters from different sequence families
were revealed to have different structural folds (Table 1). Neverthe-
less, in several cases a common underlying fold has been observed for
gene families previously believed to be unrelated. A notable example
is the so-called LeuT fold of inverted-topology repeats of ﬁve
transmembrane helices, which has been found for seven different
transporters to date, from ﬁve different sequence families [18–20]. As
of 2010, these contribute to the X-ray crystal structures of 17 different
secondary transporter proteins, which can be classiﬁed into eight
different structural folds (Table 1).
In general, a molecular mechanism of transport should be based
on structural data of, at least, the two alternative open conformations,
Ce and Ci. Whether it is necessary to have structural data of both
Table 1
Representative structures of secondary coupled transporters.
Transporter/family Coupled transport Fold Conformational state (in complex with substrate)
[in complex with inhibitor]
Res. (Å) PDB entry [citation]
1 AcrB/RND H+/drug antiport RND — 3.5 1IWG [166]
2.9 2GIF [116]
2 EcClC/CLC H+/Cl− antiport CLC — 3.5 1KPK [120]
3.0 1KPL [120]
3 GlpT/MFS Glycerol-3-phosphate/phosphate antiport MFS Ci 3.3 1PW4 [49]
4 LacY/MFS H+/sugar symport MFS CSi (thiodigalactoside) 3.6 1PV7 [51]
Ci 3.5 1PV6 [51]
Ci 3.6 2V8N [52]
Ci 3.3 2CFP [53]
Ci 2.95 2CFQ [53]
5 AAC1/MCF ADP/ATP antiport MCF Ce [carboxy-atractyloside] 2.2 1OKC [36]
Ce 2.8 2CE3 [39]
6 NhaA/NHA Na+/H+ antiport NHA Ci 3.45 1ZCD [102]
7 EmrE/SMR H+/drug antiport SMR — (tetraphenylphosphonium) 3.8 3B5D [105]
— 4.5 3B61 [105]
— (tetraphenylphosphonium) 4.4 3B62 [105]
8 EmrD/MFS H+/drug antiport MFS Cc 3.5 2GFP [50]
9 GltPh/EAAT Na+/aspartate symport GltPh Ce 3.8 IXFH [75]
Ce [(3S)-3-(benzyloxy)-L-aspartic acid] 3.2 2NWW [76]
CSec (aspartic acid, Na) 3.29 2NWX [76]
CSec (aspartic acid) 2.96 2NWL [76]
CSi (aspartic acid and sodium) 3.51 3KBC [77]
10 FucP/MFS H+/sugar symport MFS Ce [n-nonyl-β-D-glucopyranoside] 3.14 3O7Q [54]
Ce [n-nonyl-β-D-glucopyranoside] 3.2 3O7P [54]
11 LeuT/NSS Na+ /leucine symport LeuT CSec (L-leucine, Na) 1.65 2A65 [82]
CSe (L-tryptophan, Na) 2.0 3F3A [93]
CSec (L-alanine, Na)∗ 1.9 3 F48 [93]
CSec (L-alanine, Na) [clomipramine]† 1.85 2QEI [94]
CSec (L-leucine, Na) [desipramine] 2.9 2QJU [96]
CSec (L-leucine, Na) [R-fluoxetine]∗∗ 2.35 3GWV [97]
S2 (leucine, Na and octylglycoside) 2.8 3GJC [95]
12 vSGLT/SSS Na+ /glucose symport LeuT CSic (β-D-galactose, Na) 2.7 3DH4 [83]
13 Mhp1/NCS1 Na+ /hydantoin symport LeuT Ce (sodium) 2.85 2JLN [84]
CSec ((5S)-5-benzylimidazolidine-2,4-dione, Na) 4.0 2JLO [84]
Ci 3.8 2X79 [21]
14 BetP/BCCT Betaine-glycine/Na+ symport LeuT CSic 3.35 2WIT [85]
15 AdiC/APC Arginine/agmatine antiport LeuT Ce 3.2 3HQK [89]
Ce 3.61 3LRB [90]
Ce 4.0 3LRC [92]
CSec 3.0 3LIL [92]
16 ApcT/APC H+ /amino acid symport LeuT Cic 2.32 3GIA [88]
17 CaiT/BCCT L-carnitine/γ-butyrobetaine antiport LeuT CSi 3.15 3HFX [86]
Ci 2.3 2WSW [87]
CSi 3.4 2WSX [87]
Structures from the LeuT fold are marked in red.
RND: resistence nodulation division family.
CLC: chloride channel family.
MFS: major facilitator family.
MCF: mitochondrial carrier family.
NHA: sodium hydrogen antiporter family.
SMR: small multidrug resistance exporter family.
EAAT: Excitatory amino acid transporter family.
NSS: neurotransmitter solute symporter family.
SSS: sodium solute symporter family.
NCS-1: nucleobase cation symport 1 family.
BCCT: betaine-choline-carnitine transporter family.
APC: amino acid polyamine organocation transporter family.
⁎ 3F3C (phenylalanine); 3F3D (methionine); 3F3E (leucine); 3F4J (glycine) [93].
† 2Q6H [clomipramine]; 2Q73 [imipramine]; 2QB4 [desipramine] [94].
⁎⁎ 3GWU [sertraline]; 3GWW [S-ﬂuoxetine] [97].
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in order to have a conclusive description of the conformational
changes may depend on the nature of the substrate, the transporter,
or the transporter mechanism in question. Currently, structures
representing both Ci and Ce conformations are only available for a
subset of the known transporter folds (Table 1). Even when structures
are available, the limited resolution of those structures in some cases
still precludes a reliable description of the conformational changes
between the two states. Thus, so far, it has only been possible to
develop convincing molecular descriptions of the structural statesinvolved in transport for four different folds, namely the mitochon-
drial nucleotide carrier family (MCF) fold, the major facilitator
superfamily (MFS) fold, the excitatory amino acid transporter family
(EAAT) fold, and the LeuT fold.
3.1. Mitochondrial carrier fold: Salt bridge networks and the SBCGPmodel
The ADP/ATP antiporter was the ﬁrst secondary transporter to be
described by the single-binding center gated pore (SBCGP) model, in
which a central binding site is alternatively exposed to the two sides
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speciﬁc inhibitor ligands, two distinct conformational states were
deﬁned: in the Ce state the carrier accepts its substrate from the
cytoplasm, and in the Ci state the substrate can access the carrier from
the mitochondrial matrix [7,24]. The X-ray crystal structure of the
bovine mitochondrial ADP/ATP carrier (BtAAC1) solved to 2.2 Å
resolution (PDB entry 1OKC [36]) reveals a monomeric bundle of six
α-helices exhibiting a three-fold pseudo-symmetry (Fig. 2A–C).
Assuming the monomeric form of this protein is the physiologically
relevant one (see below), this large cavity is a reﬂection of probably
the largest substrate-to-protein size ratio of all the known carriers,
with the substrate being considerable in size with respect to the
protein structure.
The functional oligomerization state of the ADP/ATP carrier has for
many years been a matter of intense debate [37,38]. Thus, the
presence of artiﬁcial protein–protein interactions in the crystal
packing of the monomeric X-ray structure raised questions about
the physiological relevance of this conformation [39]. However,
corroboration was later obtained from a structure in which mono-
mer-monomer contacts in the crystal are mediated by endogenous
cardiolipin molecules (PDB entry 2C3E [39]).
Three homologous repeats, each containing the signature motif PX
[DE]XX[RK] had previously been identiﬁed in the primary structure of
the mitochondrial carriers (Fig. 2A and B) [40] and the structure
revealed the functional relevance of these motifs [41]. First, the
proline residues of the motif allow the C-terminal parts of the
transmembrane (TM) helices to kink near the base of the cavity, and
second the charged residues of the signature motif connect these
helices together via a salt bridge network (Fig. 2C) [36,42].
The structure of BtAAC1 also provided detailed information on
how the inhibitor CATR, which is known to bind to the carrier in the
Ce state only, may prevent ADP binding. CATR is bound in a large
aqueous cavity, which is wide open (with a 20 Å diameter) to the
cytoplasm, and closed by a ~10-Å-thick barrier to the mitochondrial
matrix formed by the salt bridge networkmentioned above. Thus, this
structure likely corresponds to the Ce state of the transport cycle [36].
However, although molecular dynamics simulations of spontaneous
ADP binding [43], and analysis of the structural features of CATR [44],Fig. 2. Overall fold, conformation and inhibitor binding in the bovine mitochondrial ADP/A
sequence- and structure-related repeats. (B) Cross-section through the surface representa
complex with the inhibitor carboxy-atractyloside (CATR) solved to 2.2-Å resolution (PDB ent
(displayed in stick representation with carbon atoms in black, oxygen in red and sulphur in
black lines. (C) The two helices of each repeat, colored according to (A), contribute to a six-h
motif PX[DE]XX[RK] in the odd-numbered helix (TM1, 3, 5), which is shown for repeat 3 in TM
salt bridges effectively occludes the carrier from the matrix side. An additional consensus m
(TM2, 4, 6), and is suggested to be responsible for occluding the carrier from the cytoplasmboth suggest that ADP binds at the same binding site as CATR, this has
not yet been conﬁrmed by structural analysis, and thereforewe do not
yet have conclusive support for the SBCGP model. The CATR-BtAAC1
structure may also provide an example of an inhibitor trapping the
carrier in a low-energy state, thus preventing binding of the substrate,
as discussed in section 2. However, in the absence of structural data
for the CSe state for comparison, it is not possible to say conclusively
that the CATR interactions for Ce favor one state more than those that
would be provided by ADP.
In the absence of a structure of the Ci state of BtAAC1, the
structural changes required for the translocation of the substrate also
remain speculative [42,44]. However, a plausible mechanism has been
proposed based on symmetry arguments. Speciﬁcally, it was assumed
that triplets of highly conserved, symmetry-related residues are likely
to be important for a common mechanism of transport, unlike the
residues involved in substrate binding, which will be asymmetrically
distributed (reﬂecting the asymmetry of the substrates) [41]. This
analysis revealed, in addition to the known signature motif on the
matrix side, a second symmetrically distributed and conserved cluster
of charged residues that ﬂank the putative substrate binding site on
the cytoplasmic side (Fig. 2C). The charged residues of the second
motif were proposed to form a salt bridge network when the
transporter is in the Ci state (matrix state), playing a symmetrically
equivalent role to that of the signature motif observed in the Ce
structure. Thus, formation and disruption of these two networks may
allow the major conformational switch during the transport cycle
[41]. Kinetic studies have demonstrated that many mitochondrial
carriers function in a strict exchange mode and therefore only one
substratemay be bound at a time [45,46]. Binding of phosphate anions
with three or four negative charges, as in ADP and ATP, respectively,
can be expected to provide sufﬁcient energy via electrostatic
interactions to overcome the initial activation energy barrier posed
by the salt bridge networks [43], while there is only a low probability
of disrupting the networks spontaneously [47] and therefore the
transition from outward to inward should only occur when substrate
is bound. However, because the binding site is not known it remains
unclear speciﬁcally how binding of the substrates triggers the
conformational changes required for ADP/ATP antiport.TP carrier (BtAAC1). (A) BtAAC1 exhibits a topology of six α-helices formed by three
tion of the X-ray structure of the bovine mitochondrial ADP/ATP carrier (BtAAC1) in
ry 1OKC). This structure represents a cytoplasmic open conformation (Ce). The inhibitor
yellow) is bound in a large cavity. The boundaries of the membrane are indicated with
elix bundle that is arranged as in an iris diaphragm. Each repeat contains the signature
5 (Pro229, Asp231, and Arg234) in the inset. The interaction of the charged residues via
otif [FY][DE]XX[RK] is observed on the cytoplasmic side in the even-numbered helices
ic side in a similar mechanism.
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conﬁrmation of the existence of a Ce conformation in alternating
access. Furthermore, the three-fold symmetry of the interactions in
the structure has inspired the formulation of a speciﬁc mechanism for
the conformational switch to the alternative state.
3.2. The MFS fold: The rocker-switch mechanism
Several X-ray crystal structures have been reported for members
of the MFS family, which represents the largest evolutionarily related
superfamily of secondary transporters [48]. Speciﬁcally, structures are
available for four E. coli carriers: the glycerol-3-phosphate/inorganic
phosphate antiporter GlpT (PDB entry 1PW4, [49]), the drug/H+
antiporter EmrD (PDB entry 2GFP [50]) and the lactose/H+ symporter
LacY [51–53], and very recently for the fucose/H+ cotransporter FucP
(PDB entries 3O7P and 3O7Q [54]). For LacY, which has probably been
more intensively studied than any other secondary carrier, ﬁve
structures of wild-type and mutant proteins have been solved to
date, under different conditions (PDB entries 1PV6 and 1PV7 [51],
2V8N [52], 2CFP, and 2CFQ [53]). In all these structures, the N- and
C-terminal halves of the protein each forma structural repeat consisting
of a six-helix bundle (Fig. 3A and B). These two terminal domains
are related by a pseudo-twofold symmetry axis running through theFig. 3. Overall fold, conformations and substrate binding in the MFS family. (A) Overlay
representation viewed along the plane of the membrane. The six TM helices of the N-termina
of the C-terminal domain are colored in red (LacY), yellow (GlpT) and orange (EmrD). The La
representation of the X-ray structures of LacY, EmrD and GlpT. TDG is displayed in stick repre
in (A). (C) Residues in LacY involved in TDG binding, viewed along the membrane normal, fr
of the transporter are colored blue and red, respectively. (D) Side view from the cytoplasmic c
(C1), 10 (C4) and 11 (C5) in the C-terminal repeat colored in red. The network of hydrogecenter of the transporter, perpendicular to the membrane, and are in
close contact at the periplasmic side of the membrane.
While GlpT has only been crystallized in an apo state to date, LacY
has also been crystallized with a single molecule of a lactose homolog
(ß-D-galactopyranosyl-1-thio-ß-D-galactopyranoside, TDG) bound.
TDG was found in the cavity near the approximate center of the
protein, whichwas therefore proposed to be the substrate binding site
[51]. This site is found to be a similar distance from either side of the
membrane and is close to the approximate molecular two-fold axis of
the structure. Because in both GlpT and LacY structures the putative
substrate translocation pathway is closed from the periplasmic side
and access of substrate from the periplasm is prevented, while the
pathway is clearly accessible to solutes from the cytoplasmic side,
these structures were assigned as either Ci or CSi conformations
(Fig. 3B). In the available structure of EmrD [50], by contrast, the
center of the carrier is closed to both sides of the membrane,
reminiscent of an occluded state (Fig. 3B). Finally, the recent FucP
structure appears to represent an outward-facing conformation, i.e., a
Ce state [54]. The structure of the CSi conformation of LacY (PDB entry
1PV7) was originally made possible by the introduction of a point
mutation (C154G) that resulted in a thermostable mutant that binds
substrate with high afﬁnity but is trapped in one conformation
[55,56]. The substrate-free Ci state of LacY was later captured inof structures of LacY (PDB entry 1PV7), GlpT (1P4W) and EmrD (2GFP) in ribbon
l domain are colored in blue (LacY), cyan (GlpT) and purple (EmrD). The six TM helices
cY substrate TDG is represented by black spheres. (B) Cross-section through the surface
sentation and is accessible from the cytoplasm in LacY. The color scheme is the same as
om the cytoplasmic side. The six TM helices are labeled. The N- and C-terminal domains
avity toward the proton translocation site composed of charged residues located in TM7
n bonds and salt bridges is shown as dashed green lines.
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C154G at neutral (6.5) and acidic (4.5) pH (PDB entries 2V8N, 2CFQ
and 2CFP, respectively [52,53]).
Several important conclusions could be drawn from comparison of
these structures. First, the fact that LacY and GlpT share a common
structural fold demonstrates that both symport and antiport can be
achieved with the same protein architecture (Fig. 3A) [17,28,33].
Second, the Ci conformation might represent a low free energy state
for MFS transporters, since that state has so far crystallized in
substrate-bound or apo form to high resolution [17], while the Ce
conformation has been reported so far only in the presence of a
putative inhibitor n-nonyl-β-D-glucopyranoside (β-NG) [54]. This
would be consistent with the fact that the presence of substrate
increases the population of the Ce state (see below). Third, the strong
similarity (at 2.95–3.6 Å resolution) of the mutant LacY structures in
the substrate-bound CSi and the substrate-free Ci states, limits the
possible conformational changes upon substrate binding to form the
CSi state (but not the full transition to CSe) to movements of b3.6 Å.
The fourth ﬁnding relates to coordination of the substrate [51]. In the
CSi conformation of LacY, TDG hydrogen bonds with the side chains of
ionizable residues (Fig. 3C). Furthermore, the two galactopyranosyl
rings of TDG bind to some extent to both the N- and C-terminal halves
of the protein and therefore provide a means to communicate con-
formational changes between the domains. Finally, numerous atoms
of the galactopyranosyl ring in the observed CSi conformation do
not interact directly with the protein and, as shown by molecular
dynamics simulations, are therefore instead solvated by water [57–
59]. Therefore, we suggest that the coordination of TDG observed in
the LacY CSi state represents an ‘imperfect ﬁt’ according to the
‘induced transition ﬁt’ mechanism. It would clearly be of interest to
observe the interactions of the ligand with LacY in an occluded state
(preceding CSic), as the binding site there should, by this logic,
interact optimally with the substrate.
Insights into the structure of the occluded conformation of MFS
transporters have been obtained from a 6.5-Å 3D electron microscopy
map of the oxalate/formate antiporter OxlT from Oxalobacter
formigenes [60] and a 3.5-Å X-ray structure of the drug/H+ antiporter
EmrD from E. coli [50]. Unlike the trapezoid shape (as observed from
the plane of the membrane) of the Ci structures of GlpT and LacY, the
structures of OxlT and EmrD are more rectangular in shape, and thus
more symmetric (Fig. 3B) [17]. It is important to note that substrate
is not visible in either of the occluded structures. Nevertheless, since
antiporters should never adopt an empty occluded state (Cc),
transient or otherwise, the absence of substrate in these structures
is most likely a consequence of insufﬁcient resolution [17].
As mentioned above, the known structures of MFS transporters
correspond to four distinct conformational states, CSi, Ci, C(S)c and,
very recently, Ce. The conformational changes implied by these
structures – albeit from different proteins – are supported by a large
body of biochemical and spectroscopic data indicating that LacY
undergoes conformational changes upon sugar binding that lead to
closing of the observed cytoplasmic cavity and opening of a large
hydrophilic periplasmic cavity in order to create a Ce state [61–63].
Speciﬁcally, site-directed alkylation [55,61,64–66], single-molecule
Förster resonance energy transfer [67,68], double electron-electron
resonance [69], tryptophan ﬂuorescence [70], ligand-induced ﬂuo-
rescence measurements [71,72], site-directed thiol cross-linking and
analysis of cross-linked distances in the Ci state structure [62,63,73],
all provide independent evidence that sugar and proton translocation
by LacY involves such an outward-facing conformation.
These structural and biochemical data have together made it
possible to describe a hypothetical translocation mechanism for MFS
transporters, which was the ﬁrst structure-based molecular mecha-
nism of secondary transport to be proposed, and which conﬁrms
the alternating access model and the SBCGP model to a large extent
[28]. This so-called “rocker-switch” mechanism postulates that thesymmetry-related N- and C-terminal halves of the transporter rock
back and forth against each other along the two-fold axis that runs
along the domain interface (Fig. 3A). Thus, from the observed Ci
conformation in which the periplasmic sides of the two domains
close the pathway, pivoting (or rocking) of the domains around the
approximate substrate binding site would result in the Ce conforma-
tion in which the domains become close together at the cytoplasmic
side instead [54]. The global conformational changes in this rocker-
switch mechanism may be caused by the formation and breaking of
inter- and intra-domain salt bridges [72]. For example, it has been
proposed for LacY that salt bridge interactions that characterize the
Ci state might weaken due to high-afﬁnity substrate binding (e.g.,
betweenArg144 andGlu126, Fig. 3C) [69]. Such a role for the substrate,
as well as explaining how the energy of binding may be translated
into the conformational change, is also consistent with the 'induced
transition ﬁt' mechanism. In addition, the swiveling motion of each
domain relative to the other would result in different conﬁgurations
of the binding site residues in Ce and Ci.
Although the conformational changes predicted by the rocker-
switch model are in perfect agreement with the alternating access
model, the former does not reﬂect the presence of the occluded state,
which according to the EmrD [50] and OxlT [60] structures, suggest a
clam-shell arrangement around the substrate. A more symmetrical
intermediate state is also supported by double electron-electron
resonance measurements [69], and by molecular dynamics simula-
tions of MFS transporters [57,59,74]. Thus, the domains would not
move as rigid bodies, but instead close around the substrate before
opening up again on the other side.
In summary, the structures of theMFS fold conﬁrm the presence of
a central binding site – as hypothesized in the SBCGPmodel – in which
the substrate is fully accessible in the CSi state. Moreover, the
observed CSi state provides an example of a low-energy conforma-
tional state in which the substrate is ‘imperfectly’ coordinated.
However, because of the lack of structural information about both
the Ce state of LacY and the site of proton binding [71], the precise
molecular mechanism bywhich substrate binding relates to the global
conformational change between the CSi and CSe states, has yet to
be demonstrated structurally.
3.3. Conformational changes in transporters of the excitatory amino acid
transporter (GltPh) fold
The sodium/aspartate symporter from Pyrococcus horikoshii
(GltPh), an archaeal homologue of the EAATs, was one of the ﬁrst
sodium-coupled transporters for which a 3D structure was deter-
mined (PDB entry 1XFH [75]). The X-ray crystallographic data
revealed a homotrimeric structure that forms a deep solvent-ﬁlled
bowl open to the extracellular solution. In each GltPh protomer the
ﬁrst six transmembrane helices (Fig. 4A and B, blue and cyan helices)
form a distorted cylinder, which in turn encloses a compact core
domain containing two re-entrant helical hairpins, called HP1 and
HP2 (Fig. 4A and B, yellow and red helices).
Crystal structures of GltPh have been reported in three different
conformations (Fig. 4A and D). In the ﬁrst (PDB entry 2NWX [76]), an
L-aspartate molecule and two thallium ions (i.e., as sodium replace-
ments) are bound to each protomer near the tips of the two hairpins
HP1 (Fig. 4A–D, yellow) and HP2 (Fig. 4A–D, red). On the extracellular
side of the membrane, the substrate is occluded from the aqueous
environment only by HP2, while more than 15 Å of protein separates
the substrate from the cytoplasm, all of which suggests an occluded,
CSec state of the transporter. In a second crystal structure of GltPh
in complex with a non-transportable substrate analogue L-threo-β-
benzyloxyaspartate (TBOA; PDB entry 2NWW [76]), the HP2 hairpin
(Fig. 4D, red) assumes a more “open” conformation, suggesting that
this structure mimics the Ce state in which the substrate binding site
would be accessible from the extracellular solution. In contrast to the
Fig. 4. Overall fold, conformations and substrate binding in GltPh. (A) View along the plane of the membrane of the X-ray structure of the GltPh protomer (PDB entry 2NWX) in
complex with two thallium ions (replacing sodium; purple spheres) and an aspartate molecule displayed as black spheres. The helices of each repeat are colored according to the
topology. Inset: The substrate binding sites for aspartate (black spheres with oxygen atoms in red and nitrogen in blue) and sodium (purple spheres) are located between the two
helical hairpins HP1 (yellow) and HP2 (red). (B) The topology of GltPh is characterized by the presence of repeated structural units, shown in different colors. (C) Overlay of the X-ray
structure of the CSic conformation (3KBC, light grey with TM2 in light blue and TM5 in pale cyan) with amodel of the same conformation built using the inverted-topology repeats in
the X-ray structure (dark grey with TM2 in blue and TM5 in cyan). Model and structure can be superimposed with a r.m.s.d. of 5.4 Å (excluding the loop between TMs 3 and 4), a
small amount relative to the 15–20 Å movements of the transport domain, which demonstrates that conformational changes of the two symmetry-related states involve the
inverted-topology repeats. (D) Side view of structures of GltPh: in complex with the inhibitor TBOA in stick representation (2NWW), thought to resemble the Ce state; and in a CSic
conformation (3KBC) in complex with two sodium ions (purple spheres) and an aspartate molecule (black spheres). The model of an inward-facing (Ci) state, built using the
equivalent Ce structure (2NWW) as a template, is shown on the right. HP1 and HP2 are colored in yellow and red, respectively.
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inhibition occurs by trapping GltPh in the empty Ce state, which differs
from e.g., the CSec state that interacts more favorably with the
substrate, consistent with the proposal from enzyme kinetics
(section 2). Finally, in the last year, the structure of the CSic state –
that is, after the major conformational switch – was solved by
crystallography of a cross-linked double-cysteine GltPh mutant (55C/
364C-Hg, PDB entry 3KBC [77]).
Unexpectedly, the conversion between the CSic and CSec states of
a GltPh protomer requires a piston-like movement of the entire
substrate binding domain by N15 Å across the membrane (Fig. 4D).
Remarkably, this large conformational change was correctly predicted
by structural modeling based on symmetry arguments: that is,
swapping the conformations of pairs of symmetric structural
elements that were identiﬁed in the CSe structure (Fig. 4A and B;
see below) resulted in a model of the CSi conformation that captures
the major features of the cross-linked GltPh mutant (Fig. 4C) [78](Protein Model Database (PMDB) code PM0075966; see http://mi.
caspur.it/PMDB). This approachwas also used to construct a structural
model of the Ci state of GltPh, in which HP1 is open and exposes
the substrate binding site to the cytoplasm (Fig. 4D, PMDB code
PM0075968), thus completing the set of structures in the transport
cycle [78]. The success of this approach for modeling alternate
conformations has fascinating implications for the role of symmetry
in secondary transport, as will be discussed below.
There is a novel aspect to the mechanism of GltPh transport,
compared to the rocker-switch mechanism discussed for the MFS
transporters, and that is the proposed role of conformational changes
in small sub-domains of the GltPh structure (the helical hairpins) to
allow, or prevent, access to the substrate binding site in response to a
speciﬁc event during transport. Thus, the hairpins are said to function
as thin gates although, from a structural point of view the deﬁnition of
such gates is still rather imprecise. Note that, if the same concept of
thin gates were to be applied to MFS transporter function, it might
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GltPh the backbone of the helical hairpin can move. Thus, the size of a
gate (i.e., whether a channel is prevented from forming by, e.g., side
chain or backbone elements) is likely to vary for different transporters
andmay be reﬂected in the binding kinetics. The assignment of HP2 as
a thin extracellular gate was inferred from comparison of the CSec and
Ce structures [75] (Fig. 4A and D), and is supported by the markedly
dynamic nature of HP2 in simulations of substrate-free GltPh [79,80],
as well as ﬂuorescence changes in reporter groups covalently linked to
HP2 [81]. The most recent models and structural data indicate that
HP1 forms the intracellular gate in a symmetry-related way [77,78].
Interestingly, a consequence of the GltPh mechanism is that the
interactions with helices of the N-terminal cylinder keep one of the
two gates locked shut at any given time, similar to the doors in an air
lock. Moreover, during the shuttling of the transport domain there are
likely to be many intermediate conformations in which both hairpins
are locked shut by those same interactions, implying that the GltPh
alternating access mechanism is inherently efﬁcient at preventing
leakage.
Molecular dynamics simulations indicate that binding of substrate
and sodium ions, which are thought to trigger the major conforma-
tional change from CSec to CSic, may also be required for the closure of
the corresponding thin gates [80], e.g., the transition from Ce to CSec
by closure of HP2 (Fig. 4A and D). While the 'induced transition ﬁt'
mechanism suggests that the intrinsic binding energy of substrate-
carrier interaction drives the CSec→CSic conformational change, we
propose that for GltPh this energy is required to keep the extracellular
gate closed (Ce→CSec) and thus to form the substrate binding
site (see section 4). Once the hairpin gate is closed, there should be no
additional energy required. Thus, the CSec→CSic transition in which
the “closed” transport domain moves against the ﬁxed parts of the
structure, will presumably occur stochastically, as a result of thermal
energy alone, although this does not necessarily mean that the
transition is rapid. An equivalent transition has been suggested to
occur for the apo transporter (GltPh) in order to complete the transport
cycle [77].
In the GltPh fold, gating and substrate translocation are inherently
linked, due to the fact that the gates (HP1 and HP2) also contribute
to the substrate binding site (Fig. 4A, inset). Moreover, the whole
binding domain including both gates, acts as a carrier module that
shuttles the substrates towards the cytoplasm during the CSec→CSic
transition, resulting in a signiﬁcant change in the location of the
substrate during translocation (Fig. 4D). Thus, transport by GltPh does
not obey the central binding site requirement proposed in the SBCGP
model.
In summary, although structural data for the GltPh fold conﬁrmed
aspects of the concept of gating during the alternating access
mechanism (i.e., in the Ce→CSec transition), other aspects of the
transport mechanism described in this section are most likely speciﬁc
to the GltPh fold.
3.4. Conformational changes in LeuT fold transporters
For a long time, the rocker-switch and GltPh-type gating mecha-
nisms were presented as two opposing models for the function of
secondary transporters. This situation changed with the increase in
structural data for transporters with the LeuT fold, starting in 2005
[82]. This fold was ﬁrst observed for LeuT from Aquifex aeolicus, a
bacterial homologue of the neurotransmitter sodium symporter (NSS)
family, and was subsequently found in six other proteins (Table 1):
the Na+/galactose symporter vSGLT [83] from Vibrio parahaemolyticus
of the solute/sodium symporter (SSS) family, the benzyl-hydantoin
transporter Mhp1 [84] from Microbacterium liquefaciens of the
nucleobase/cation symporter (NCS1) family, the Na+/glycine betaine
symporter BetP [85] from Corynebacterium glutamicum and the L-
carnitine/γ-butyrobetaine antiporter CaiT [86,87] from E. coli orProteus mirabilis, both members of the betaine-choline-carnitine
transporter (BCCT) family, the H+-coupled amino acid transporter
ApcT [88] from Methanocaldococcus jannaschii as well as in the
arginine/agmatine antiporter AdiC [89,90] from E. coli, both of which
are members of the amino acid, polyamine, and organocation (APC)
transporter family.
Although differing in total number of TM helices, all the LeuT fold
transporters share a repeated structural motif of ﬁve TM helices. The
ﬁrst ﬁve TM helices are related to the second ﬁve by a two-fold
pseudo-symmetry axis, running parallel to the membrane plane.
In many cases the ﬁrst helix of each of these repeat units contains
unwound helical regions that are responsible for forming substrate
interactions [18]. Such unfolded stretches of protein expose main-
chain hydrogen-bonding partners, creating a polar environment
suitable for coordination of substrate and ions [91].
The ﬁrst two helices of each repeat in LeuT come together to form a
four-helix bundle that is surrounded by an outer scaffold of helices
(Fig. 5A). Depending on the speciﬁc structure, this helix bundle either
contains within it (e.g., for BetP), or lines one side of (e.g., for LeuT),
the central translocation pathway and the binding sites for substrate
and co-substrate ions. Within the outer scaffold of helices, other
symmetry-related helices (the third and fourth of each repeat) form
V-shaped elements, that together create a second sub-domain,
described as looking like a hash symbol (#) (Fig. 5A) [21]. The
conserved 10 TM-helix core of the LeuT fold appears to be the
essential component required for transport function, although in
some cases this core structure is supplemented by peripheral
structural elements common to a speciﬁc transporter family.
Almost every structure of this highly conserved protein fold reveals
a different conformational state of the alternating access cycle (Table 1,
Fig. 1). A Ce state was observed for AdiC [89,92], and for one of the
three Mhp1 structures [84], while several structures of LeuT [93–97]
and one of Mhp1 [84] show CSec conformations with the substrates
bound to a common location approximately halfway across the
membrane bilayer, and in the center of the core domain (Fig. 5A and
B). Conservation of the substrate location was observed in the
alternate states. Speciﬁcally, in structures of vSGLT [83], CaiT [86,87],
and AdiC [90] with the substrate binding site occluded or accessible
from the cytoplasm, the CSic and CSi states were identiﬁed,
respectively. Additional structures of Mhp1 [21], and CaiT [86,87]
reveal open, substrate-free Ci conformations. Two somewhat more
symmetrical, occluded structures that nevertheless contain some form
of pathway to the cytoplasm: one with substrate bound (CSic, BetP
[85]), and an apo form (Cic, ApcT [88]), have also been reported.
Although the general location of the substrate binding sites appears
conserved, the composition of the residues coordinating the substrates
varies signiﬁcantly. For example, in the Na+-coupled symporters
LeuT, vSGLT, BetP and Mhp1, only one of the two sodium ion binding
sites is conserved. In LeuT, the sodium ion at the so-called Na1 site is
directly coupled to the carboxy oxygen of the substrates, and is not
present in other transporters, whereas the second Na2 site of LeuT
appears to be conserved in both vSGLT and Mhp1 (see section 4).
Based on these structures, as well as non-equilibrium molecular
dynamics simulations [98] and single-molecule FRET data on LeuT
[99], a gating-type model has been proposed to describe the common
transport mechanism for the LeuT fold. In this mechanism, gate
opening would occur via ﬂexing of the ﬁrst helix of each repeat in a
way that would render the binding sites accessible. Bending of these
helices appears to be feasible, based on, e.g., comparison of substrate-
free conformations of AdiC with substrate-bound conformations of a
high-afﬁnity AdiC mutant [90]. Still, whether such ﬂexing of the ﬁrst
helix of each repeat is sufﬁcient to cause exchange from CSe to CSi
remains to be demonstrated. Notably, the fact that binding of
tryptophan to LeuT creates a Ce state of the transporter provides a
second example of inhibition by trapping of a low-energy state to
which the substrate, by contrast, binds less favorably.
Fig. 5. Overall fold, conformations and substrate binding in LeuT fold carriers. (A) All LeuT fold transporters share a repeated structural motif of ﬁve TM helices that have inverted
topologies and are closely intertwined. The ﬁrst two helices of each repeat (N1-N2 and C1-C2) form a four-helix bundle that is surrounded by a scaffold that includes the hash domain
(N3-N4 and C3-C4) and two arms (N5 and C5, shown in green). The ﬁrst ﬁve TM helices (blue) are structurally homologous to the second ﬁve (red). The two-fold pseudo-symmetry
axis, running parallel to the membrane plane, which relates the repeat units is displayed as green arrow. (B) Cross-sections through the three structures of Mhp1 viewed from the
plane of the membrane. The three structures are: in the Ce conformation in complex with a sodium ion (PDB entry 2JLN); in the CSec conformation in complex with (5 S)-5-
benzylimidazolidine-2,4-dione (5FH), shown in stick representation in black andwith one sodium ion (PDB entry 2JLO); and in an Ci conformation (2X79). In the Ce and Ci states the
substrate location observed in the CSec state is indicated in grey. (C) The bundle, hash regions and the arms of Mhp1 in the Ce (blue) and Ci (orange) conformations, viewed from the
periplasm (left) and the cytoplasm (right). Some loops have been removed for better visualization. The bundle and the hash domainmove relative to one another, similar to a rocker-
switch mechanism. (D) Side view of the ﬁfth helix of each repeat (N5 and C5) in the Ce (purple) and Ci (orange) conformations of Mhp1, showing the ﬂexing of these helices around
their glycine-rich midsections, forming the thin gates.
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similar to a rocker-switch mechanism, was ﬁrst put forward based on
biochemical accessibility measurements on a mammalian LeuT
homolog, and on a molecular model of the CSi state of LeuT created
by swapping the conformations of the internally symmetric structural
motifs [100] (see also GltPh, above). Speciﬁcally, the LeuT model
suggests that during the conformational switch from CSe to CSi the
four-helix bundle (Fig. 5B) would be relatively rigid, and would rock
against the scaffold. Such a mechanism inherently allows for coupling
of the opening of one side of the pathway to closure of the other side,
would maintain the integrity of a chloride ion binding site within the
bundle, and is consistent with the fact that the helices in the bundle
are connected by very short loops which may limit the relative
movements of the helices [19].
Structures of Mhp1 [21,84], which have been solved in Ce (PDB
entry 2JLN), CSec (PDB entry 2JLO) and Ci (PDB entry 2X79)
conformations (Fig. 5A), and molecular dynamics simulations thereof
[21], however, suggest a combination of the two types of mechanism,
containing features of both rocker-switch and gating models [22].
Thus, during the main conformational switch, the bundle (along with
various peripheral helices) moves relative to the other parts of the
structure (primarily the hash domain), similar to a rocker-switch
mechanism (Fig. 5B). At the same time, helices connecting the bundle
and hash domains (the ﬁfth helix of each repeat) bend and ﬂex at
glycine residues near their midpoints (Fig. 5B and C). This ﬂexing aids
in the occlusion of the substrate by reversibly folding over the top of
the binding site, and thereby these helices act as thin gates (Fig. 5C).
Such movements may be limited to the NCS1 family however, since
equivalent helix-breaking residues are not found in all LeuT fold
transporter families. Unlike the GltPh mechanism, the closing or
opening of these thin gates does not involve residues that coordinatethe substrate in the CSec state. However, small obstructions to
substrate release (thin gates) are also observed in the LeuT, AdiC and
vSGLT structures, and these are indeed formed by side chains from the
binding site. Thus, the LeuT fold presents two types of gating
mechanisms by which bound substrate can be occluded.
A crucial question is how the two steps of the LeuT foldmechanism
(the domain-rocking movement and the gating movements) are
related sequentially. It has been proposed that after substrate binding
to the Ce or Ci state, closure of the thin gates (whether side chains or
ﬂexible helices) occludes the substrate in the primary binding site,
creating the CSec or CSic state [18]. Unbinding would therefore
involve the reverse, opening process. The energy cost of such thin gate
substrate occlusion events may well be minimal, as the conforma-
tional states involved are likely to be sampled due to thermal
ﬂuctuations, similar to the observation for the thin gates of GltPh.
Subsequent to the occlusion step, the domain-rocking movement
(opening and closing of the thick gates) would then be responsible
for switching the transporter between the CSe and CSi states. This
transition would reorient the entire membrane-spanning bundle
of helices along a central axis approximately perpendicular to the
membrane, as observed for the transition in Mhp1 (Fig. 5). An
advantage of such a pseudo-rigid-body conformational change is
that it efﬁciently synchronizes the opening on one side with the
closure on the other side [100]. The energetic barrier to such a large
conformational change in antiport and symport, according to the
transition state theory of enzymology, must be lowered by the
binding of all required substrates, although it is still expected to be
larger than the barrier to opening and closing of the thin gates.
However, a detailed understanding of which transporter-substrate
interactions are essential for changing the energetic landscape in this
way, remains elusive.
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molecular dynamics simulations of LeuT [98] have suggested the
presence of an additional binding site, known as S2, in a vestibule
between the primary site and the bulk extracellular solution. Based on
these data, it has been proposed that the simultaneous occupancy of
the two sites triggers the intracellular release of sodium ions and of
substrate from the primary site. X-ray diffraction studies of LeuT,
however, do not show binding of the substrate anywhere other than
the primary binding site, although the Ce conformation of LeuT in
complex with tryptophan does bind a second tryptophan molecule at
S2 [93], and antidepressants [94,96,97], and detergent molecules [95]
have been observed in that exact location, providing interesting
examples of non-competitive inhibition. Structural and biochemical
studies of CaiT have identiﬁed an analogous binding site in the
intracellular vestibule [86], as well as a possible cooperative binding
site on the extracellular surface that is occupied by either L-carnitine
or γ-butyrobetaine [86,87]. The extent and purpose of such allosteric
mechanisms remain to be ﬁrmly established, since it is also possible
that such sites are simply transiently occupied as substrates move
towards the primary binding site [18].Fig. 6. Symmetry relation between structural repeats in the four secondary transporter fold
four structures, substrates (yellow spheres), proline (yellow) and glycine (orange) residues
(cyan arrow). (A) Side view of the X-ray structure of the ADP/ATP carrier (BtAAC1) in ribbon
light pink (repeat 3). They are related by a three-fold symmetry axis (green arrow, green trian
repeats is parallel to the direction of substrate translocation pathway (cyan arrow), which al
terminal (magenta) and C-terminal (grey) repeats are related by a two-fold axis (green arrow
substrate translocation pathway (cyan arrow). While the TM helices of each repeat contai
residues (yellow) at the periplasmic and cytoplasmic ends of each helix. (C) Side view of the X
bundle is shown in magenta, the hash region in dark grey and the two arms in green. Nume
spanning helices. The inverted structural repeats (TM1-TM5 and TM6-TM10) are related by
the ‘glycine belt’ in the halfway across the membrane. The translocation pathway (cyan arro
normal. (D) Side view of the X-ray structure of GltPh. Repeat 1 is colored in light grey, repeat
are colored in green. Both inverted structural repeats pairs (repeat 1–2 and repeat 3–4) are r
about ~15° from the membrane plane. The translocation pathway (cyan arrow) runs through
observed for the LeuT fold.In summary, the structural data for the LeuT fold suggests a
combination of the rocker-switch and gating-type mechanisms in
order to achieve alternating access. In contrast to GltPh, it has generally
been assumed for the LeuT fold that the substrate binding location is
essentially unchanged during transport, consistent with the SBCGP
model, although this remains to be demonstrated since the CSe→CSi
transition is yet to be described structurally for the same protein.
3.5. Impact of symmetry on fold-speciﬁc conformational changes
The topologies of theMCF, MFS, EAAT and LeuT folds appear at ﬁrst
glance to be difﬁcult to compare, due to signiﬁcant differences in the
arrangements of the helices, the lengths of those helices, as well as
degrees of bending and unwinding. However, as alluded to above, it
turns out that each of the four folds can be subdivided into a number
of repeated structural elements (or ‘repeats’), which are related to
each other by a distinct symmetry axis (Fig. 6). Remarkably, the
conformational changes that those proteins undergo all appear to
involve symmetry-related movements of those structural repeats. For
example, the conformational change described for LeuT by structurals (MCF, MSF, LeuT and GltPh fold) relative to the substrate translocation pathway. In all
are highlighted, as are the symmetry axis (green arrow) and the translocation pathway
representation. The three repeats are colored inmagenta (repeat 1), grey (repeat 2) and
gle) that is perpendicular to the plane of themembrane. The symmetry axis relating the
so runs through the center of the carrier. (B) Side view of the X-ray structure of LacY. N-
) running through the center of the carrier, parallel to the membrane normal and to the
n only a few proline residues (orange), the fold is characterized by numerous glycine
-ray structure of LeuT. TM11 and TM12 have been removed for better visualization. The
rous glycines (yellow) and prolines (orange) are found halfway across the membrane-
a two-fold symmetry axis (green arrow) running parallel to the membrane plane along
w) runs through the center of LeuT but adopts an angle of about ~15° to the membrane
2 in light pink, repeat 3 in magenta and repeat 4 in dark gray. The hairpins HP1 and HP2
elated by a two-fold symmetry axis (green arrow) along the ‘glycine belt’ at an angle of
the center of GltPh at an angle of about ~15° from the membrane normal, similar to that
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the inverted-topology repeats in the CSec crystal structure, as
mentioned above. Speciﬁcally, the sequence of the ﬁrst repeat was
allowed to adopt the conformation of the second repeat, and vice versa,
and this process led to a model of the CSic state because the inherent
differences in the repeats [19,100]. This outcome could also be achieved
for GltPh, even though its architecture is signiﬁcantly more complex
[78]. Thus, the symmetry in the structure encodes the conformational
changes required for transport. However, as will be discussed below,
the orientations of the internal symmetry axes that those movements
follow differ substantially between structural families.
In MCF and MFS proteins the structural repeats also show
sequence homology, providing strong support for the idea that
these repeats resulted from gene duplication of an ancestral (carrier)
protein [40,48]. In the MCF family, there are three repeats of two
helices each, which are related by a three-fold symmetry axis running
parallel to the membrane normal, straight through the center of the
carrier (Fig. 6A). Residues believed to be involved in conformational
changes, i.e., prolines in the signature motif of each repeat, strictly
follow the three-fold symmetry. In MFS transporters, the repeated
domains are related by a two-fold symmetry axis (Fig. 6B) rather than
a three-fold axis, and yet in both MCF and MFS folds, the respective
symmetry axis runs along the translocation pathway. Indeed, this co-
incidence of the symmetry axis and the pathway is clearly well suited
to formation of alternating, symmetry-related states. However, the
speciﬁc conformational changes required for transport are clearly
different for proteins with two-fold versus three-fold symmetry. For
two-fold symmetry, a rocker-switch (or clamping and releasing)
movement of the repeats along their symmetry axis is well suited to
opening and closing the central binding site. Primarily rigid-body
movements are also consistent with the domains being made up of
relatively straight TM helices, with very few signiﬁcant deviations
from α-helicity, containing glycine-rich (bendable) segments only at
their extra-membranous ends. By contrast, the three-fold symmetry-
related repeats of theMFC proteins have been proposed to undergo an
iris-like twisting of the TM helices relative to the short helices on the
matrix side [41]. In such amovement, the cytoplasmic andmatrix parts
of the helicesmight be able to bend at the pronounced hinge regions in
the TM helices that are formed by prolines from the signature motif.
In the LeuT fold the repeats are related by a two-fold symmetry
axis as in LacY, but here no sequence homology is observed between
the repeats. Moreover, in the LeuT fold the symmetry axis runs
parallel to the membrane plane and consequently the repeats have
inverted topologies (Fig. 6C). Because this axis runs through the
repeats (rather than between them), their helices are interwoven.
Nevertheless, together the repeats form two structurally distinct
protein domains (the bundle and hash domains). This is in contrast to
the MFS proteins, where the axis runs between the repeats and those
repeats are largely structurally independent. Another interesting
consequence of the inverted-topology of the repeats in LeuT is that the
symmetry axis and translocation pathway run nearly perpendicular to
one another, while in the MFS fold they run along the same axis.
Remarkably, the end effect for these two very different folds (MFS
and LeuT) is that the conformational switch probably occurs by the
rocking of two domains against one another along an axis that runs
perpendicular to the membrane plane. In the case of the LeuT fold this
motion arises from rocking of the bundle and hash domains relative to
one another, rather than the repeats, and thus the axis of this motion
does not run parallel to the symmetry axis as for the MFS fold, but
rather along an axis running through the center of the 10-TM core,
perpendicular to the membrane plane (Fig. 6C).
In GltPh the symmetry relationships are rather more complex
[77,78]. Speciﬁcally, two independent sets of repeats are related to
one another by two-fold symmetry (Fig. 4B), and the symmetry axis is
now tilted with respect to the membrane plane, running from the
outermost corner of each protomer towards the center of the trimer(Fig. 6D). As for the LeuT fold, the symmetry axis and translocation
pathway are nearly perpendicular to one another. Similar to LeuT, the
repeat units of each pair have inverted topologies and come together
to form two structurally distinct protein domains (transport domain
and scaffold). The entire transport domain containing the binding
site and both gates (as well as some movement of the adjacent lipid-
facing TMhelices 3 and 6), translates towards the cytoplasm during the
CSec→CSic transition, while the scaffold domain remains more or less
static. These relative movements can be interpreted, to some extent,
as a rocking motion along an axis that is tilted with respect to the
membrane normal, i.e., parallel to the translocation pathway.Moreover,
the orientation of external and internal gates is strictly related by the
symmetry axis that relates the two inverted-topology repeats.
Finally, we note that elements from both the MFS and GltPh folds
are found in the LeuT fold. In addition to the two-fold symmetry that is
shared by theMFS fold, the gating in the LeuT fold, i.e., occlusion of the
substrate binding site, occurs via thin gates as in the GltPh mechanism.
In some cases, the thin gates contain secondary structure elements
as in GltPh, and in others the occlusion is formed by individual side
chains. In marked contrast to GltPh however, the binding site in LeuT
does not move during translocation.
3.5.1. Status of the transport mechanism in the remaining folds
We have discussed molecular transport mechanisms for four folds
in detail, but what about the remaining four folds, for which such a
descriptionwas not possible? There are several reasonswhy structural
information available for these four carrier folds did not easily lead into
a description of conformational changes that ﬁts within an alternating
access mechanism. These include lack of structural data in different
conformations, and insufﬁcient resolution in the case that the
substrates consist entirely of ions. In the following, we will brieﬂy
discuss the limiting factors for each of the remaining folds.
3.6. Sodium-coupled proton antiport in NhaA
The Na+/H+ antiporter NhaA has a unique ability for pH sensing
and has been studied extensively using biochemical approaches for
many years [30,101]. The characteristic feature of the structural fold of
NhaA is a pair of discontinuous TM helices with opposite orientations
to one another in the membrane, reﬂecting also the presence of
inverted-topology repeats [22,102]. The unwound stretches that cross
in the middle of the membrane are accessible from the cytoplasm by a
broad funnel and thus the conformation of this structure was assigned
to Ci state. A shallow periplasmic funnel to the crossing stretches,
separated from the cytoplasmic funnel by a non-polar barrier, was
also observed. Moreover, because crystallization was performed at
acidic pH, where NhaA is inactive, this structure probably represents
an inactivated state of the protein. Thus, together these aspects
conspire to complicate the assignment of the state of this structure.
Due to the modest resolution of the data (Table 1), neither
substrate could be assigned to the structure, although it has been
proposed based on molecular dynamics simulations that the cyto-
plasmic funnel is accessible to water and hydrated cations, while the
narrow periplasmic funnel can only be accessed by non-hydrated Na+
ions [103,104]. Interesting proposals relating to the activation
mechanism, involving e.g., rotation of a helix adjacent to the crossing
helices, have also been put forward based on the molecular dynamics
simulations [103,104]. Nevertheless, since these simulations are based
on a structure of the inactive state at low resolution additional
experiments and additional structures will be required to conﬁrm or
disprove these ﬁndings.
3.7. Multi-drug resistance by EmrE
Two X-ray structures of EmrE from E. coli, which is an archetypal
transporter of the small multidrug resistance (SMR) family have been
Fig. 7. Carrier model for a symport and a strict antiport mechanism. C is the carrier
protein, S and T are substrate and co-substrate, respectively. The subscripts indicate
the respective carrier conformations e, i, and c, for externally and internally exposed,
and occluded state. Broken connecting lines indicate a 'forbidden' step in the cycle.
(A) Symport is shown in a symmetrical ordered mechanism. In the binding order of co-
substrate and substrate, T is ﬁrst and S is second. For transport of T and S to be coupled,
the CeT↔CiT transition is forbidden. Unidirectional uptake in the symport mode
involves the whole cycle, whereas exchange (and counterﬂow) of substrate would only
require the upper half of the cycle. (B) In strict antiport of the two substrates T or S, the
Ce↔Ci transition is not allowed to occur.
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EmrE is an H+-coupled antiporter that extrudes toxic polyaromatic
cations from the cell. EmrE consists of only 4 TM helices, considered to
be too small to form an entire transporter unit alone andwas therefore
assumed to be a functional dimer [106,107]. Indeed, a dimeric
arrangement was observed in a 7.5-Å cryo-electron microscopy map
of EmrE, which displayed a physiologically unusual asymmetry [108].
A structural model generated for this map guided by conservation
analysis [109] agrees remarkably well with the X-ray structures
mentioned above [105]. In these structures, the protomers are
oriented antiparallel in the membrane. The physiological relevance
of the antiparallel dimer is a matter of some controversy, as there is
support for a parallel conﬁguration from biochemical and spectro-
scopic studies [110,111]. Nevertheless, there is general agreement
that EmrE can insert into the membrane in two opposing orientations
at the same time [112] (i.e., it has two different topologies), which is
a novel and remarkable architecture for a secondary transporter.
The proposed substrate binding site, which consists of aromatic
and negatively charged residues, is located at the dimer interface.
Interestingly, in both orientations the substrate binding site would be
expected to contain a perfect two-fold symmetric distribution of
residues, a unique property of homodimeric proteins, such as the SMR
transporters.
3.8. Proton-dependent multi-drug efﬂux by AcrB
AcrB, a member of the resistance nodulation cell division (RND)
family from E. coli, is part of a three-component system together with
AcrA and TolC that is responsible for transport of noxious substances
such as dyes, detergents, bile salts and antibiotics out of the cell. AcrB
is responsible for the drug speciﬁcity and energy transduction in this
tripartite system [113,114]. Unlike the secondary transporter struc-
tures discussed in the previous sections, the AcrB protomer contains,
aside from its membrane components, two large periplasmic
segments that comprise the TolC docking domain. Its structure has
been solved in a three-fold symmetric conformation but also later in
an asymmetric conformation, which is thought to represent the
physiologically relevant form [113,115].
The AcrB protomers in the asymmetric trimer structure [116,117]
were suggested to represent consecutive steps of a transport cycle.
However the terminology of outward- or inward-facing state of the
alternating access was not attributed; instead the three states were
designated as loose (L), tight (T) and open (O), which reﬂects the
formation of several different tunnels connecting TolC with the
membrane outer leaﬂet. One reason for this different assignment is
that, unlike the classical alternating access mechanism, the substrate
and counter-substrate (protons) for AcrB are recruited from different
compartments. That is, while the drugs bind from the outer leaﬂet
of the membrane and are released into the periplasmic funnel formed
by TolC, protons bind from the periplasm and are released to the
cytoplasm. Hence, there is no common substrate binding site that is
accessible from one side of the membrane during transport. The
proposed cycling mechanism in fact resembles more closely that of a
peristaltic pump, with analogies to themechanism of ATP synthesis by
the F-ATPase [116]. Therefore, description of conformational changes
in the AcrB antiporter does not easily ﬁt into a general alternating
access mechanism.
3.9. Chloride conductance and transport by CLC proteins
EcClC from E. coli is a bacterial homologue of the chloride channel
and transporters (CLC) family. It has been shown that this bacterial
homologue is not an ion channel, but functions rather as a Cl−/H+
antiporter [118]. This remarkable ﬁnding suggests that the structural
boundary separating channels and transporters is not as clear-cut as
previously thought [119]. The structure of this homodimeric trans-porter exhibits a complex topology, with two structurally related
inverted-topology halves within each protomer [120]. The Cl−
translocation pathway is an hourglass-shaped pore, located at the
interface between the two halves of each protomer, containing a
selectivity ﬁlter formed by OH groups of one serine and one tyrosine
side chain as well as amide NH groups of the protein backbone at the
constriction. Two of three binding siteswere occupied by chloride ions
in the structure of the wild-type protein, and occluded at the third
(extracellular) binding site by the side chain of a conserved glutamate
residue Glu148 [120]. It has been suggested that the conformations
of the aforementioned tyrosine and serine side chains coordinating
the second chloride binding site constitute an intracellular gate,
which prevents free exchange of the ion with the cytoplasm, and
would therefore correspond to an occluded CSic state. However, an
assignment to a deﬁned conformational state during the alternating
access cycle is not trivial. The transported chloride anionsmove along a
preformed pathway in this transporter similar to the way they would
in ion channels, and the relatively fast transport kinetics (which were
estimated to be on the microsecond time-scale), suggests no large
conformational changes other than the movement of the glutamate
side chain to the third binding site of chloride [121,122].
4. Coupling in secondary transport
4.1. Uniport, symport and antiport mechanisms require different sets of
rules
The concept of coupling of the free energy of the electrochemical
potential of one solute to the transmembrane movement of another is
integral to a discussion of mechanistic differences between uniport,
symport and antiport mechanisms in secondary active transport. In
this framework, coupling is described on a formal level by a set of
rules [11,16]. For coupled secondary transport, the underlying rule is
simply that transport of the substrate is allowed to occur only when
the co-substrate is also transported. More speciﬁcally, in kinetic
schemes similar to Fig. 1, the switch from the e (=external)
conformation of the transporter to the i (= internal) conformation
is allowed for some intermediates or complexes, but forbidden for
others (Fig. 7). In a strict antiport system, such as the mitochondrial
ADP/ATP carrier, the binary complexes with either ADP or ATP are
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such as LacY, a conformational switch is allowed in the ternary form,
i.e., with both substrate (lactose) and co-substrate (proton) bound, as
well as for the empty carrier, while the binary complexes are locked.
These rules are able to describe how uncoupling of a coupled vectorial
process is prevented, but the structural basis of these coupling rules is
only now beginning to be understood. We wish to describe, for
example, which structural properties deﬁne the ability of a particular
bound state of a transporter to undergo the conformational Ce↔Ci
switch, and why this depends on the type and number of bound
substrate ligands.
In the following, we will address the mechanisms of ﬁrst antiport,
and then symport, and consider, in each case, which energetic and
kinetic characteristics are associated with the aforementioned rules.
Note that this mechanistic discussion requires a clear distinction to be
made between the nature of the carrier protein itself, and environ-
mental factors such as substrate concentration gradients and the
membrane electrical potential.
4.2. In antiport, substrate binding provides the energy for the major
conformational change
If the above formal deﬁnition of rules is combinedwith the concept
of induced transition ﬁt (see section 2), the mechanism of antiport,
which is the simplest form of coupled transport, is particularly easy to
understand. This is because in both 'inward' and 'outward' directions,
the catalytic energy necessary for effective substrate translocation, i.e.,
for lowering the activation energy barrier for the conformational
change of the carrier protein, is provided in both directions by the
intrinsic energy of substrate binding at the appropriate side of the
membrane. The only requirement in terms of coupling is that there is
not enough catalytic energy available to allow interchange between
the Ce and the Ci conformations of the carrier in the absence of bound
substrates, implying a very high activation energy barrier for the
conformational change of the empty carrier (Fig. 7). Thus, the
direction of antiport, i.e., the extent to which each of the substrates
is transported in a given direction, depends simply on the concentra-
tion ratio of the two substrates corrected for their afﬁnities to the
binding site.
4.3. Antiport of charged species affects, and is affected by, the membrane
electrical potential
Even for antiport the mechanism becomesmore complicated if the
two antiport substrates differ in charge. Under these conditions,
transport becomes inﬂuenced by an electrical (membrane) potential.
The best studied example of this effect is counter-transport by the
mitochondrial ADP/ATP carrier, which, under energized conditions of
mitochondria in the presence of a high electrochemical potential,
favors the export of ATP4- out of mitochondria in exchange for import
of ADP3- into mitochondria, along the membrane potential, i.e., with
positive polarity outside [123]. Another well-described example is
substrate/product antiport in bacteria [124], which frequently
involves substrates with different charge states. The role of the
membrane electrical potential in secondary transport is discussed in
more detail in the context of symport mechanisms (see below).
In the case of the ADP/ATP carrier, the differently charged species
become accumulated in a way that diminishes the mitochondrial
membrane potential. In the case of precursor/product antiport, by
contrast, asymmetric substrate movement driven by their chemical
potentials (opposing concentration gradients of two differently
charged substrates) actually generates a transmembrane electrical
potential. An interesting recent example of the latter mechanism is
exhibited by the AdiC protein [89], for which 3D structures were
recently reported [89,92]. AdiC catalyzes the exchange of external
arginine for its cytosolic decarboxylation product agmatine, effec-tively resulting in the export of protons, and concomitant generation
of a membrane potential. In the light of these examples, the energetic
equivalence of the two components of electrochemical potentials,
namely the chemical and the electrical components, becomes clear.
That is, for the ADP/ATP carrier the electrical component drives
formation of the chemical component, while for AdiC the chemical
component drives formation of the electrical. An understanding of
this equivalence is instrumental for our discussion of driving forces
in coupled symport mechanisms.
4.4. Symport requires the empty carrier also to change conformation
An attempt to explain symport mechanisms in the conceptual
framework used above, however, introduces new challenges. This is
because, in unidirectional transport, irrespective of whether it is
coupled to the gradient of a co-substrate (symport) or not (uniport),
the return of the carrier protein to the initial ground state requires a
conformational change of the empty protein from Ci to Ce, or vice
versa (Fig. 7). Remember that, in the case of strict antiporters, such a
step must be forbidden, i.e., characterized by a very high activation
energy barrier. This raises the question of what property makes the
energetic barrier of this step sufﬁciently low that it is accessible
without the aid of substrate during symport. In some cases, catalytic
energy for this step might be derived from the transmembrane
potential (see section on membrane electrical potential, below).
Another possibility is that the intrinsic energy from the ligand binding
step is stored in some way, and then utilized in this part of the cycle.
Alternatively, the structural features of symporter proteins may differ
from those of antiporters in a way that allows for an inherently low
activation energy barrier and thus allows stochastic Ce↔Ci exchange
under physiological conditions.
The kinetic difference between Ci↔Ce exchange of the empty and
the substrate-loaded carrier becomes obvious in the light of a simple
observation. Speciﬁcally, in symporters where it has been studied, such
as the glucose carrier from erythrocytes [125], substrate antiport has
also been detected. Importantly, this basically unproductive form of
catalytic activity is, in the presence of sufﬁciently high substrate
concentrations on both sides of the membrane, faster than the
productive, physiologically relevant, unidirectional transport function.
The obvious explanation for this rate change is a lower activation energy
barrier for substrate antiport because of the energy provided by binding
of the substrate in the reorientation step of the catalytic cycle.
4.5. Ce↔Ci exchange and the rate-limiting step in symport
The observation of substrate exchange by symporters also suggests
that the rate-limiting step (i.e., that with the highest activation
energy) in the complete, physiologically relevant symport cycle is
found in the later stages of the kinetic cycle (Fig. 7). One possibility is
that the conversion of the empty carrier from the Ci to Ce state is rate-
limiting. Thus, even though the energetic barrier for this event is
lower than during antiport, it may still have the highest barrier of
all the steps in the cycle. From a structural perspective, the Ce↔Ci
conversion is also the most likely candidate for the rate-limiting step,
since it requires the largest conformational change. However,
substrate dissociation is also a possible candidate for the rate-limiting
step in symport.
In fact, under speciﬁc conditions, deﬁned by the substrate and co-
substrate concentrations or by the membrane electrical potential,
another step in the cycle such as substrate dissociation may, in
practice, be slower than the theoretical rate-limiting step for the
carrier. There are examples of the two aforementioned situations
among structurally and biochemically well-characterized systems. For
the intestinal Na+/glucose cotransporter SGLT1 [126], a homolog
of the structurally characterized vSGLT protein [83], analysis of
steady-state and presteady-state currents using electrophysiology
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rate-limiting step is either substrate or co-substrate binding, or
translocation of the empty carrier, depending on the concentrations of
the two substrates and on the membrane potential. For LacY, the H+/
lactose cotransporter from E. coli, evidence has been provided that
dissociation of co-substrate protons from the cytoplasmic side of
the carrier may become a rate-limiting step under speciﬁc conditions
(see below).
Now that we have described the kinetic implications of the
coupling rules imposed during symport, we can begin to consider the
consequences of those rules in terms of, e.g., the order of co-substrate
binding, or the nature of the binary complex (i.e., with only one
substrate bound). Again, we use LacY [28] as an example symporter,
because, even though the mechanism of coupling is still poorly
understood on the molecular level, a wealth of pertinent biochemical,
biophysical, and kinetic data is available.
4.6. Binding of co-substrates in symport is interdependent and ordered
In considering the binding of substrates during symport, it is
important to note that the different substrates of LacY, and of
secondary transporters in general, do not react with the protein
independently from one another, but that substrate binding and
release in most cases follow an ordered kinetic mechanism. Indeed, it
has been pointed out that this represents one of the few instances in
biochemistry in which such an ordered mechanism is essential for the
successful functioning of an enzyme [16]. Moreover, thorough
analysis of kinetic considerations indicates that a binding order in
which the driving substrate (e.g., protons for LacY and Na+ for SGLT1)
is “ﬁrst on” during loading, and “ﬁrst off” during unloading, actually
minimizes the extent of uncoupled reactions in the catalytic cycle
[11]. In the case of LacY, where the binding order at the periplasmic
site has been established, the proton does indeed bind before the
lactose substrate, but dissociation instead occurs in the reverse order
[128]. It can therefore be assumed that binding of lactose requires
prior protonation of speciﬁc charged residues, most probably E269
and H322 [28,129], or, as suggested by the authors, binding of a
hydronium ion to these residues [71]. In mutagenesis studies it has
also turned out that binding and transport of one of the substrates
cannot be altered without affecting the properties of the other. As will
be discussed below, from a structural perspective this can result from
one of two situations. Either the coupling ion (Na+ or H+) interacts
with the substrate, and therefore contributes to the binding site
directly, or the ion causes an allosteric change in the structure (or
structural ensemble) of the protein as a whole, and thereby indirectly
allows formation of the binding site.
4.7. Prevention of uncoupling during symport
To prevent uncoupling, binding of just one of the two substrates
must necessarily lead to the formation of a 'locked' state of the carrier
that is statistically unlikely to undergo the translocation-related
conformational switch. We note that in the course of the extensive
mutational analysis of LacY, interesting mutant forms have been
identiﬁed that exhibit both possible variants of an uncoupled
phenotype, namely (i) that catalyze lactose transport uncoupled
from proton translocation, and (ii) that allow proton ﬂux uncoupled
from lactose transport [130–133]. The binary complexes of these
mutants therefore apparently have amuch higher statistical probability
of undergoing the conformational switch than the binary complexes of
the wild-type protein. Remarkably, these observations suggest that
single amino acid side chains can govern the coupling rules of a given
transporter. Itwould beof great interest toobtain structural information
for these mutants, as this may unveil the structural correlates for
the rules that govern locking and unlocking of speciﬁc steps in the cycle
[11,132].4.8. The role of the membrane electrical potential in symport
An interesting question relating to coupled transport is how
electrical potentials can be included in the mechanistic concept, or,
in other words, how the membrane potential imposes directionality
on secondary active transport. Again, LacY and SGLT1 provide useful
examples on which we can base our discussion. For SGLT1, the
membrane potential was found to exert a signiﬁcant inﬂuence on only
one step in the catalytic cycle, namely the translocation of the empty
carrier, although it also has a minor effect on Na+ binding to the
extracellular binding site [127]. All other steps were found to be
independent of the membrane potential.
In proton-coupled transport by LacY, the role of the membrane
potential and the question of the rate-limiting step is more complex. A
number of results indicate that, although protonation or deprotonation
are not rate limiting for either for active transport driven by the
electrochemical proton potential or for lactose exchange (see Fig. 7),
they do seem to be rate-limiting during passive, proton-coupled
efﬂux of lactose driven by its own gradient [28,134,135]. In addition,
kinetic measurements reveal that ΔΨ and ΔpH (i.e., the two
components of the electrochemical proton potential) both have a
strong and equivalent effect on the apparent substrate afﬁnity Km in
LacY, that is, the rate of transport [136]. Finally, electrophysiological
measurements conﬁrm that a late step in the reaction cycle of LacY,
such as co-substrate release or carrier reorientation, is connected
with the energetic input of the membrane potential also under
conditions of substrate-gradient driven lactose efﬂux [137,138].
Based on these observations, Kaback and colleagues have suggested
that deprotonation of LacY at the cytoplasmic face of the transporter is
not only the rate-limiting step in the transport cycle, but also the
particular kinetic step that is modulated by the electrical potential
[28,129,137,138]. That is, a high membrane potential is proposed to
accelerate deprotonation of CHi, which would increase the population
of the Ci state (Fig. 7A), and this in turn would increase the probability
of empty LacY to switch from the Ci to the Ce state. Taken together, the
evidence suggests that, at least under speciﬁc conditions, a step other
than the reorientation step can indeed be the rate-limiting step,
and furthermore that the deprotonation step at the cytoplasmic face of
the protein is the partial reaction within the cycle that is inﬂuenced
by the membrane potential.
The question remains, however, how in this model the electrical
potential can change the afﬁnity of the co-substrate binding
site, which, for LacY, would mean changing the pKA of the proton
binding site that is exposed in the CHi conﬁguration. One possible
explanation of the inﬂuence of the electrical gradient is that it
depends on the net charge of the carrier itself. In particular, for the
potential to affect the least efﬁcient step (presumably reorientation
of the empty carrier), we can assume that the empty transporter,
but not the ternary complex (with lactose and protons) carries a net
negative charge that is capable of sensing the electrical potential.
Thus, the electrophoretic impact of ΔΨ (positive outside) would be
to provide the catalytic energy necessary to increase the efﬁciency
of the reorientation step in the translocation cycle [139]. Although
this concept would in fact provide a mechanistic explanation for
a direct inﬂuence of electrical potentials on the transport cycle, no
structural information in support of this mechanism is currently
available.
Having now described the implications of coupling rules in both
kinetic and mechanistic terms, we can proceed to consider what the
recent structural and dynamic insights from crystallographic and
computational studies reveal about the molecular counterparts of
these theoretical and empirical observations. We will ﬁrst address
sodium-coupled transport from two different structural folds (LeuT
and GltPh), for which sufﬁcient data is now available for a detailed
description. This will be followed by a brief discussion of proton-
coupled transport, including for LacY.
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The X-ray crystal structure of LeuT, ﬁrst solved at 1.65 Å resolution,
provided the ﬁrst detailed insights into the interactions of the
coupling ions to any secondary transporter [82]. Although the electron
density of sodium is indistinguishable from that of a water oxygen, the
nature of the coordination in the structure [82], comparison with
biochemical data [140–143], and subsequent computational analyses
[98,144–146] together provide convincing evidence for two sodium
binding sites in LeuT, which turn out to be rather distinct in their
nature.
The ﬁrst of the two sodiumbinding sites, Na1, remarkably, includes
the amino acid substrate itself, which directly coordinates the ion
through a backbone carboxylate oxygen atom [82]. Such a direct
interaction allows a satisfying molecular description of coupling in
which the binding afﬁnities of the substrate and ion are inexorably co-
dependent. Support for this concept has been provided by molecular
dynamics free energy calculations [98,145], which also suggest that
Na1 is a rather high-afﬁnity site [98,144]. Together these data indicate
that the electrostatic component of the interactions is the primary
requirement in ion-based coupling in LeuT, although coordination
(van der Waals) and desolvation effects will obviously also play some
roles [144].
The second site for sodium in LeuT, Na2, is separated from Na1 by
one transmembrane helix (TM1) and is located slightly more towards
the cytoplasm than the substrate binding site. Thus, although direct
coupling to the substrate does not occur for this ion, the presence of
the substrate occupying the extracellular pathway may provide a
means of coupling by inhibiting re-release of the ion [21].
At Na2, the sodium ion is coordinated by polar groups from the
protein backbone, as well as by side chain hydroxyl groups [82].
Equivalent side chains have also been identiﬁed by biochemical and
structural studies as probable binding sites in other sodium-coupled
transporters of the same fold, including vSGLT [83], sodium-iodide
symporter [147], γ-amino butyric acid transporter GAT-1 [140], BetP
[84,85] and Mhp1 [84], suggesting a common sodium binding site
[18,20]. Remarkably, structures of the ApcT and CaiT proteins reveal
that the electrostatic component of monovalent cation binding to
Na2 may be mimicked by a basic amino acid side chain, which may
remove the ion requirement in antiport by CaiT [86,87], and possibly
also introduce proton coupling in the case of ApcT [88]. Thus, the
electrostatic component appears to be the most critical feature of the
ion-protein interaction also at this second binding site in the LeuT fold.
Together these observations suggest that the LeuT fold architec-
ture contains a common requirement for interactions at the location
of Na2. In fact, assuming that a rocker-switch-type conformational
change (involving relative movements of the bundle and the hash
domain) connects CSi and CSe, the Na2 site is situated precisely at the
nexus of the two major moving parts of the protein, providing direct
interactions to both the bundle (TM1) and the hash domain (TM8)
that may enable it to directly modulate the conformational change
[19,100]. Further support for this proposal comes from biochemical
studies of an NSS transporter, which indicate that sodium binding to
Na2 results in changes in accessibility of TM1 [148].
Interestingly, the Na2 ion in the CSe state of LeuT has been
calculated by free energy perturbation molecular dynamics simula-
tions to have a relatively weak binding afﬁnity [98,144]. By contrast,
more qualitative molecular dynamics simulations [21,149], as well as
the fact that the coordinating groups are relatively distant from one
another in the structures, indicate that in the CSi or Ci conformations
reported for vSGLT [83] and Mhp1 [21], respectively, this sodium
binding site is essentially not intact. These observations raise an
interesting conundrum since it is presumed that the substrates must
bind efﬁciently to both inward- and outward-facing conformations of
the carrier in order for a symmetric (reversible) symport process to be
possible. This discrepancy might be explained by assuming someplasticity in the CSi/Ci states (i.e., a large conformational ensemble),
so that as the domains move closer together, the ion may bind and
then facilitate the full transition to the Ce states.
For ApcT, it has been proposed that protonation and deprotonation
of a lysine at Na2, may also modulate the conformational change, by
analogy with sodium binding and unbinding [88]. Speciﬁcally, in the
known Cic structure of ApcT, this lysine residue is predicted to be
deprotonated, and the local interactions with surrounding Na2
residues are minimal. Upon protonation, however, the charged side
chain might optimize the local interactions with TM1 and TM8 akin
to the observed sodium–ion coordination in LeuT, thereby directly
modulating the conformations of these helices by the electrostatic
properties of the side chain, and leading to formation of the Cec
state. Presumably, the relatively rigid nature of the bundle and hash
domains [21] allows for those local conformational changes to be
translated into the full transition to the other state.
Finally, aside from their sodium dependence, eukaryotic members
of the NSS family also have a strong dependence on chloride. Studies
inspired by sequence analysis, and by calculations of the electrostatic
potential of the available structures, suggest that this requirement is
also primarily electrostatic. Speciﬁcally, the chloride dependence can
be replaced biochemically by the introduction of an acidic side chain
as found in chloride-independent prokaryotic homologs such as LeuT
[150,151]. Interestingly, the acidic side chain introduces an additional
requirement for the bacterial transporters, namely for proton
counter-transport, so as to neutralize the charged residue while the
protein reverts to Ce from Ci [151]. Although two similar and plausible
structural models of the chloride binding site in the eukaryotic NSS
transporters have been proposed [150,151], conﬁrmation of the
binding site location and the nature of its interactions will require
further evidence from biochemical and structural studies.
4.10. Ion binding and coupling to glutamate transporters
For the EAAT family of transporters there is also structural
evidence for two cation binding sites, which, again, are rather distinct
from one another [76]. This evidence was obtained from thallium
replacement studies rather than direct evidence of sodium binding,
although recent evidence suggests that thallium replaces sodium in
many of its key roles [152]. The ﬁrst site, Na1, is buried deep in the
transport domain (Fig. 4), and includes coordination by a conserved
glutamate residue [76,153], as well as residues from TM7 and the thin
intracellular gate HP1 [79]. In contrast, the second proposed site,
Na2 is located between the tip of HP2 and residues in TM8, very close
to the aqueous solution (Fig. 4), and is formed only by backbone
carbonyl atoms, making it difﬁcult to conﬁrm by mutagenesis.
Nevertheless, molecular dynamics simulations suggest that sodium
ions are reasonably energetically favored in both these sites [80,154].
Nevertheless, glutamate transport requires symport of three, not
two, sodium ions, raising the question of where the third ion might
bind. There have been numerous proposals for this site [79,155–157],
although the strongest evidence points to two alternatives. The ﬁrst,
which has been named Na3′ is coordinated by an aspartate residue
from TM7, and has support from biochemical, electrophysiological
[154,155] and computational studies [154,157], although it has been
suggested that this site cannot be bound simultaneously with the
Na1 site (which is adjacent), and thus perhaps it is only transiently
occupied [154]. The second proposed site, Na3, identiﬁed by theoretical
approaches [154,156] and supported by electrophysiological and
ﬂuorescencemeasurements [154] is coordinated inpart by the substrate
(glutamate) carboxylate groups, and thus would provide a simple
explanation for direct coupling, similar to the role of Na1 of LeuT. A
direct ion–substrate interaction would also explain the interdepen-
dence of ion and substrate speciﬁcity observed for neuronal EAAT
transporters [158]. Finally, computational studies have also provided a
molecular description of the order of extracellular substrate binding to
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gate, and supported by evidence from electrophysiological studies
[159]. Speciﬁcally, it has been proposed that in the apo state, in which
HP2 tends to be open, one sodium would enter to the deep Na3′ site,
after which Na3 would bind, followed by substrate, reﬂecting their co-
dependent binding nature. Once bound, the substrate would alter
the afﬁnity for the ion bound to the deep Na3′ site so that it moves into
the Na1 site, which has a more favorable binding energy under these
conditions [154]. Importantly, binding of substrate, through direct
interactions would increase the probability that the extracellular
HP2 gate is closed, thus creating the Na2 binding site [160]. However,
only upon binding of the third (chronologically) sodium ion to the
Na2 site would the gate be completely closed [80,154]. Complete
closure of the thin gates, as mentioned above, is presumably the
main requirement for allowing the major CSec↔ CSic transition of the
GltPh fold. Thus, by regulating the thin gate closure, as well as one
another's binding afﬁnities, the substrate and the sodium together
enforce many of the coupling rules for co-transport by this family of
transporters.
Thus, structural, biochemical and computational studies have
together led to important gains in understanding of the molecular
details of coupling by glutamate transporters. Similar insights will
now be required for intracellular gate (HP1) opening, and cytoplasmic
substrate release, as well as the subsequent re-conversion of the
transporter to the extracellular states. Differences between the
prokaryotic transporter GltPh, for which the Ci→Ce conversion can
occur in the empty state, and the eukaryotic EAATs, which instead
require potassium counter-transport, will be of particular interest.
Such insights may help to explain why transporters of the same
architecture can have such different energetic barriers in a given
step in the transport cycle, which lead to their categorization as
symporters instead of antiporters, or vice versa.
4.11. Proton coupling
Structural insights into proton-dependent coupling are clearly
more difﬁcult to obtain than for other ion-dependent modes, given
the resolution of protein crystallography data currently accessible
(~2 Å). Nevertheless, the structural data at least indicates which
ionizable residues in the protein are likely to interact with protons,
and which might be involved with substrate binding. In FucP, for
example, only two ionizable side chains are found in the substrate
pathway. One of these has been proposed to be protonated in the
inhibitor-bound Ce structure based on molecular dynamics simula-
tions, whereas biochemical assays suggest that protonation of the
second side chain is required for substrate binding [54].
For LacY, all available structures appear to be in the protonated
form, potentially because they were all determined at pH levels lower
than the pKa for sugar binding, which is 10.5 [72]. Nevertheless, in
those structures it is possible to identify several ionizable residues in
the C-terminal 6-helix bundle, located approximately in the center of
the molecule opposite the sugar-binding site (Fig. 3D), which are
proposed to play a key role in H+ translocation [28,128,129,161,162].
One of these residues (Glu269), as part of a wider salt bridge network,
can also form a salt bridge with an arginine (Arg144) from the lactose
binding site, providing a direct connectionwithin the protein between
the two sites that may facilitate coupling of their binding (Fig. 3C).
Indeed, the formation of this salt bridge is proposed to correlate with
substrate binding, whereas the same residues may form alternate salt
bridges with neighboring residues in substrate-free and outward-
facing states [28]. The fact that these salt bridge networks also connect
the two terminal domains of the protein provides some hints of the
way in which binding of protons may couple to the conformational
change. Nevertheless, detailed molecular mechanisms coupling
proton and substrate binding to one another, and to conformational
changes in LacY, remain rather speculative.4.12. An exception to the rules: Antiport meets channel
The ClC Cl−/H+ antiporter from E. coli is a fascinating system, not
only in its structure (see section 3), but also with respect to its
transport function. It represents a remarkable exception from the
general ‘rule’ described in the major part of this review. Since both
the structure and function of EcClC is fundamentally different from
the other classes of transporters, much can be learned about the basic
concept of secondary transport from a thorough comparison of this
individual with the rest of the carriers [119,121]). A kinetic analysis of
EcClC would not give rise to any major suspicion of its unusual nature,
since its function is tightly coupled antiport with a stoichiometry of
2 Cl− ions exchanged for one proton [118]. However, EcClC is unusual
in several ways. In terms of structure, the most obvious difference of
EcClC to other secondary carriers is the presence of a channel-type
pathway. Chloride anions move along a preformed pathway in a
single ﬁle movement, consecutively occupying the three Cl− binding
sites. Cl− is bound to a central binding site in dehydrated form [122],
as if in a selectivity ﬁlter of a channel. Furthermore, unlike secondary
antiporters in which the two substrates use the same pathway
through the protein, Cl− and H+ appear to travel along different,
channel-type pathways through ClC, although the proton pathway
has not been resolved structurally. There are also a number of basic
mechanistic aspects by which EcClC differs from a typical secondary
antiporter. Antiporters bind their substrates alternately in the two
different states and shuttle them across the membrane in ping-pong
like conformational changes according to the alternating access
model. In contrast, ClC is able to bind both its substrates simulta-
neously, and, importantly, protonmovement along its pathway seems
only to be possible when the central anion binding site is occupied by
Cl− [118]. Apparently, carrier-type antiport function and substrate
coupling are imposed on the channel-like ClC protein by the following
features: two glutamate residues at the entrances of the substrate
pathway that gate the movements of both H+ and Cl−; two separate
pathways for H+ and Cl− [163,164]; and ﬁnally the presence of
internal binding site(s) that coordinate the functionally coupled
movement of the two substrates.
Consequently, we learn from EcClC that the function of coupled
secondary transport can be achieved also by a construction funda-
mentally different from those of the rest of the carrier systems, that is,
using the basic protein machinery of a channel. As long as exclusive
alternating access of central substrate binding site(s) is guaranteed
and as long as a molecular mechanism is available that functions
according to speciﬁc rules of coupling, the result is coupled antiport
with a kinetic behavior surprisingly similar to ‘normal’ antiport
carriers. Thus, whereas the basic rule of coupling in typical secondary
antiporters requires that the Ce↔Ci transition in the absence of
bound substrate is not allowed, in the case of EcClC the basic
requirement is a channel equipped with two gates carrying central
binding site(s) to which one substrate (proton) will bind only when
the corresponding site is already occupied by the other (Cl−).
In summary, the latest structural data, supported by biochemical
and computational studies, provides evidence for a number of
different molecular mechanisms by which the binding of secondary
transporter co-substrates becomes coupled. For example, coordina-
tion of one substrate by another provides a direct interaction that
imposes co-dependence on their afﬁnities. More long-distance effects
appear to arise from electrostatic interactions, such as for chloride
stabilization of sodium binding. Finally, steric inhibition, such as by
the hydantoin in the pathway in Mhp1, may also modulate co-
substrate unbinding and thus enhance its afﬁnity.
Very recent studies also suggest, in microscopic detail, ways in
which the substrates or co-substrates can modulate conformational
changes in the carrier protein itself, and therefore dictate the rules of
coupling for symport or antiport. These include: direct constraints on
the thin gates as in the case of ion and substrate interactions with HP2
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second cation site in the LeuT fold; as well as the disruption of speciﬁc
salt bridge networks, as in the case of LacY. Emerging from these data,
then, we begin to see a diverse set of solutions that carrier proteins
have evolved in order to solve the requirements of coupling in
secondary active transport.
5. Conclusions and perspectives
Secondary transport systems are fascinating molecular machines
in several aspects. They are perfect little energy converters transform-
ing electrochemical energy into vectorial movement, and vice versa. In
the history of research on membrane-bound transporters, several
phases can be perceived: ﬁrst a conceptual one in which, for example,
the alternating access model was proposed; this was followed by a
biochemically active period deﬁned by numerous kinetic, biophysical
and biochemical investigations on carrier function; ﬁnally, very
recently, a structural one, leading to the discovery of an increasing
number of 3D and 2D structures of these transporters. This recent
development has been supported and complemented substantially by
the application of sophisticated computational studies, which allow
the information provided by X-ray structures and by biochemistry to
be extended and explained. It is the main focus of this review to point
out that it should now be possible to close the circle and turn to a new
conceptual age in which the combined knowledge of these proteins
provides a basis for testing, modifying and ﬁnally verifying funda-
mental concepts of transport.
In spite of the stimulating situation in whichwe ﬁnd ourselves, it is
obvious that we still have far to go to reach the goal of a complete
understanding of the mechanics of transport proteins and, in
particular, of coupling in secondary transport. What are the main
obstacles to reaching these goals? On the one hand, there are a number
of rather basic limitations. For example, we urgently need more
structures of individual carriers in different conformations. More
precisely, we are looking not only for transporters forwhich structures
of both Ce and Ci states are available, e.g., in the case of LacY, as well as
occluded and open states, but also for structures of carrier proteins in
as many different states as possible with respect to binding of
substrates and, in particular, co-substrates (ions). On the other hand,
even though the availability of protein structures of a number of
carriers has signiﬁcantly improved our understanding of the mecha-
nism of secondary transport, we urgently need higher resolution in
most cases to allow for unequivocal description of conformational
events and, in particular, for accurate descriptions of binding sites.
Unfortunately, it may be difﬁcult to overcome these resolution limits
because of inherent problems, at least in some cases. It is quite possible
that the characteristic properties inherent to carrier-type membrane
proteins limit the resolution that X-ray crystallography may bring:
Secondary transporters are in general highly ﬂexible proteins with
rather small hydrophilic surfaces for appropriate crystal contacts.
Beyond the availability of numerous transporter structures with
sufﬁciently high resolution, we will also urgently need the continued
support of solid data arising from the application of tried and tested
biochemical techniques. There are numerous areas where these
techniques continue to be extremely helpful and can help compensate
for insufﬁcient resolution in structure. Sophisticated kinetic analysis
allows, for example, for a deﬁnition of the binding order of substrates,
which is essential for accurate descriptions. Similarly, elaborate cross-
linking or molecular scanning techniques can provide information
on dynamic aspects of neighboring residues.
Probably the most signiﬁcant barrier to a complete mechanistic
picture of secondary transport is the lack of understanding of the
molecular mechanisms of coupling, from several perspectives. First,
we are still far from a true mechanistic understanding of coupled
substrate and co-substrate movement, except for strict antiport
systems. In some cases this is due to the lack of structures ofsufﬁciently high resolution harboring bound co-substrate ions. In
other cases it is due to the inherent difﬁculty of localizing protons as
co-substrates. Second, we would like to understand how the electrical
potential contributes to the directionality of secondary transport
beyond a simple picture of the electrogenic movement of a charged
carrier complex, and moreover, how the equivalent effects of ΔΨ and
ΔpH on transport may be explained mechanistically. Third, we are
far from understanding substrate/co-substrate stoichiometry and the
reasons why it can vary in closely related carrier proteins, or even
single-residuemutants. Nothing, for example, so far explains why two
closely related glycine transporters couple different numbers of
sodium ions to the transport of a single substrate [165]. Finally, we
wish to know more about the structural correlate of the fundamental
‘rules of coupling’ in the different systems. It would be attractive to
understand mechanistically, why, for example, the empty carrier in
antiport systems is not able to undergo the Ci↔Ce transition, whereas
in structurally similar symport systems this transition is allowed.
In conclusion, with this reviewwe hope to have begun a discussion
in which the fundamental concepts of transport can be brought to
bear on the microscopic details of their molecular mechanisms, and
vice versa.
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